Entry,Protein,Gene,Urine,Plasma,Serum
A0A5F5XCT0,Alpha-1-B glycoprotein,A1BG,31.5,31.6,31.5
M3W0W4,Alpha-1-B glycoprotein,A1BG,20,19.9,20.2
M3W3E7,Alpha-2-macroglobulin,A2M PZP,24.3,25.7,25.6
A0A5F5Y1U9,Alpha-2-macroglobulin,A2M PZP,26.6,30.6,30.6
A0A5F5Y328,Alpha-2-macroglobulin,A2M PZP,17.5,19.4,19.7
A0A337S3K5,Alpha-2-macroglobulin like 1,A2ML1,22.3,26.7,26.8
M3WN23,ATP binding cassette subfamily A member 6,ABCA6,19.1,11.6,11.3
A0A337S6A5,ATP binding cassette subfamily B member 9,ABCB9,21.8,22.8,18.3
A0A337RXE3,Putative protein-lysine deacylase ABHD14B (Alpha/beta hydrolase domain-containing protein 14B),ABHD14B,25.8,20.8,21
A0A337SDS2,ABI family member 3 binding protein,ABI3BP,20.1,19.2,18.6
A0A337S133,Costars family protein ABRACL (ABRA C-terminal-like protein),ABRACL,17.8,18.8,18.2
A0A337S9Y6,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.7)",ACADM,19,10.2,11
M3W0B5,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-methylbutyryl-coenzyme A dehydrogenase)",ACADSB,20.8,18.8,19.4
A0A5F5XDQ7,Aggrecan core protein (Cartilage-specific proteoglycan core protein),ACAN,20.5,17.9,18.7
A0A5F5XYF2,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,17.1,14,14.5
M3VZ88,acetyl-CoA C-acetyltransferase (EC 2.3.1.9),ACAT2,13.5,11,11.7
A0A5F5XZX3,acetyl-CoA C-acetyltransferase (EC 2.3.1.9),ACAT2,18.7,16.3,16.1
A0A2I2UTZ7,Angiotensin-converting enzyme (EC 3.4.-.-),ACE,26.6,25.6,25.8
Q56H28,Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (EC 3.4.17.-) [Cleaved into: Processed angiotensin-converting enzyme 2],ACE2,30,23.6,23.7
A0A337S319,2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase),ACMSD,18.5,18.9,14.5
M3VWD8,Cytoplasmic aconitate hydratase (EC 4.2.1.3) (Citrate hydro-lyase) (Iron-responsive element-binding protein 1),ACO1,21.4,23.7,22.1
A0A5F5XXE9,Acyl-coenzyme A oxidase,ACOX3,19.6,19.3,20.4
A0A337S8L4,Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.2) (EC 3.1.3.48) (Low molecular weight cytosolic acid phosphatase),ACP1,19.6,16.8,17.7
A0A337S165,Lysosomal acid phosphatase (EC 3.1.3.2),ACP2,22.6,20.3,19.7
A0A337SAA6,Lysosomal acid phosphatase (EC 3.1.3.2),ACP2,19.6,17.3,18.1
A0A2I2UHD0,Long-chain-fatty-acid--CoA ligase (EC 6.2.1.15) (EC 6.2.1.3) (Acyl-CoA synthetase) (Long-chain acyl-CoA synthetase),ACSL5,14.8,17.4,15.4
A0A5F5XWN0,"Actin alpha 1, skeletal muscle",ACTA1 CCSAP,22.6,18.5,18.4
A0A5F5XDM4,"Actin, cytoplasmic 1 (Beta-actin)",ACTB,26.5,23.6,23.6
M3W6I2,"Actin, cytoplasmic 2 (Gamma-actin)",ACTG1,22.5,19.9,19.9
A0A337SCW1,"Actin, gamma-enteric smooth muscle (Gamma-2-actin) (Smooth muscle gamma-actin)",ACTG2,26.3,23.2,23.2
A0A2I2U3E4,Alpha-actinin-4 (Non-muscle alpha-actinin 4),ACTN4,22.9,21.3,21.3
M3W8V8,Serine/threonine-protein kinase receptor (EC 2.7.11.30),ACVR1,19.8,14.8,14.3
A0A337RUC4,receptor protein serine/threonine kinase (EC 2.7.11.30),ACVR1B,24.6,17.8,17
M3VUE2,Serine/threonine-protein kinase receptor (EC 2.7.11.30),ACVRL1,20.6,17,18.4
A0A337RV46,N-acyl-aliphatic-L-amino acid amidohydrolase (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase),ACY1,23.7,21.8,21.9
A0A337SC15,N-acyl-aliphatic-L-amino acid amidohydrolase (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase),ACY1,21.5,18.3,18.6
A0A2I2UWI1,Disintegrin and metalloproteinase domain-containing protein 10 (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease),ADAM10,21.8,20.5,20.5
A0A2I2V2H3,ADAM metallopeptidase domain 8,ADAM8,14.3,11.5,11
A0A337S9H1,ADAM metallopeptidase domain 9,ADAM9,18.6,14.2,13.9
M3X5J0,ADAM metallopeptidase with thrombospondin type 1 motif 13,ADAMTS13,18.6,19.1,18.1
A0A5F5XCM7,ADAM metallopeptidase with thrombospondin type 1 motif 2,ADAMTS2,22.2,13.8,14
M3WNU5,ADAMTS like 2,ADAMTSL2,19.8,17.7,17.7
M3VVC4,ADAMTS like 4,ADAMTSL4,21.3,20.5,20.1
A0A337SUP1,Adhesion G protein-coupled receptor E2,ADGRE2,23,12.1,12.3
A0A5F5XF14,Adhesion G protein-coupled receptor E5,ADGRE5,21.2,14.4,14
A0A2I2UTI9,Adhesion G protein-coupled receptor F5,ADGRF5,19.7,20,19.7
A0A2I2UM02,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56),ADGRG1,23.8,19.8,19.9
A0A5F5XG72,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56),ADGRG1,22.6,20.3,20.7
A0A2I2U088,Adhesion G protein-coupled receptor G6,ADGRG6,18.8,17.5,17.8
A0A2I2UB34,Adhesion G protein-coupled receptor L1,ADGRL1,25.1,19.7,19.8
A0A2I2U0D3,Adhesion G protein-coupled receptor L2,ADGRL2,21.7,20.4,20.7
A0A2I2U5R8,Adhesion G protein-coupled receptor L3,ADGRL3,22.9,16.7,16.5
A0A337SL34,Adhesion G protein-coupled receptor L4,ADGRL4,19.9,15.8,15.8
A0A3B0IPC1,Adiponectin A,ADIA,19.9,24.2,24.3
A0A3B0J2D0,Adiponectin D,ADID,20.6,24.3,24.3
A0A337SQU4,ADP dependent glucokinase,ADPGK,18.8,19.4,19.9
A0A2I2U1Z3,Afamin,AFM,26.2,28.8,28.7
M3XC81,Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF),AFMID,19.7,18.9,19.6
M3X557,Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin),AFP,20.2,21.6,21.7
A0A5F5XS55,Aspartylglucosaminidase,AGA,23.5,19.3,19
M3X0F1,Aspartylglucosaminidase,AGA,19.6,16,16.1
Q6KCA0,Alpha1-glycoprotein acid,agp,26.1,27.3,27
A0A5F5XI81,Agrin,AGRN,21.7,20,18.9
A0A2I2UUP6,Angiotensinogen (Serpin A8),AGT,31.8,28.1,28
A0A2I2U551,Adenosylhomocysteinase (S-adenosyl-L-homocysteine hydrolase),AHCY,19.7,17,17.7
A0A337SD37,Alpha-2-HS-glycoprotein (Fetuin-A),AHSG,28.3,30.8,30.8
A0A5F5XVZ8,Alpha-2-HS-glycoprotein (Fetuin-A),AHSG,20.5,16.4,15.2
A0A5F5XHI8,Aldo-keto reductase family 1 member A1 (EC 1.1.1.19) (EC 1.1.1.2) (EC 1.1.1.20) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (Glucuronolactone reductase),AKR1A1,23.1,20.8,20.2
A0A5F5XWS8,Aldo-keto reductase family 1 member B1 (EC 1.1.1.21) (EC 1.1.1.300) (Aldose reductase),AKR1B1,22.7,19.7,19.8
A0A5F5XQC7,NADP-dependent oxidoreductase domain-containing protein,AKR1C3,15.5,11.4,10.3
M3WA76,Aldo-keto reductase family 7 like (gene/pseudogene),AKR7L,21,19.5,20.1
P49064,Albumin (allergen Fel d 2),ALB,35.1,36.6,36.6
A0A2I2U7Y0,Albumin,ALB,29.8,31.5,31.4
A0A2I2UX74,CD166 antigen (Activated leukocyte cell adhesion molecule),ALCAM,24.1,22.7,21.7
M3WAV4,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH1A1,24.7,23.9,24.4
A0A337RUT4,10-formyltetrahydrofolate dehydrogenase (EC 1.5.1.6),ALDH1L1,20.2,11.3,12.9
A0A337STY8,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2)",ALDH2,18.1,14.9,14.1
A0A337RWN1,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH7A1,12.7,11.3,13
A0A337S2J9,Aldehyde dehydrogenase 8 family member A1,ALDH8A1,21.7,19.5,19.4
A0A337SF20,Aldehyde dehydrogenase 8 family member A1,ALDH8A1,17.3,19.7,17
M3W1Z4,4-trimethylaminobutyraldehyde dehydrogenase (EC 1.2.1.19) (EC 1.2.1.3) (EC 1.2.1.46) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1) (Formaldehyde dehydrogenase) (Gamma-aminobutyraldehyde dehydrogenase),ALDH9A1,21.9,20.1,19.7
A0A337S416,Fructose-bisphosphate aldolase (EC 4.1.2.13),ALDOA,24.7,23.5,23.6
A0A5F5XME0,Fructose-bisphosphate aldolase (EC 4.1.2.13),ALDOB,24.8,22,21.1
A0A337SRA7,Alkaline phosphatase (EC 3.1.3.1),ALPI,20.3,15.3,15.2
Q29486,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)",ALPL,25.7,22,22
A0A337SNZ0,Protein amnionless,AMN,23.1,22.1,22
A0A337SBE3,Protein amnionless,AMN,24.6,22.6,22.4
A0A5F5Y013,Alpha-amylase (EC 3.2.1.1),AMY2B,26.3,25.6,25.6
M3X5H0,Alpha-amylase (EC 3.2.1.1),AMY2B,20.2,17.7,17.5
A0A337SEZ4,Angiopoietin-2,ANGPT2,23.5,22.3,22.2
M3X749,Angiopoietin 4,ANGPT4,23.6,19.6,19.7
A0A5F5XNX6,Angiopoietin like 1,ANGPTL1,22.8,21.1,21.5
M3WA23,Angiopoietin like 2,ANGPTL2,26.8,23.2,23.3
M3WET8,Angiopoietin like 3,ANGPTL3,27.1,20,20
A0A5F5Y1K1,Angiopoietin like 6,ANGPTL6,23.7,18,18.3
A0A337SS27,Aminopeptidase N (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (Microsomal aminopeptidase),ANPEP,21.1,18.4,17.9
P79171,Aminopeptidase N (AP-N) (fAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13),ANPEP APN,26.6,23.4,23.4
A0A337SIV7,ANTXR cell adhesion molecule 1,ANTXR1,25.4,20,20.2
A0A337SPR7,ANTXR cell adhesion molecule 2,ANTXR2,18,19,19
A0A5F5XLK1,Annexin,ANXA1,20.3,18.2,19.2
M3W3I3,Annexin A10,ANXA10,19.5,14.7,14.6
A0A5F5XPA1,Annexin,ANXA11,26,21.9,22
M3XFZ3,Annexin,ANXA11,20,11.6,11
A0A337SIG2,Annexin,ANXA13,22.6,20.5,20.6
A0A337SCD2,Annexin,ANXA2,24.5,20.8,21.1
A0A337S137,Annexin,ANXA4,24.9,22,22.3
A0A337S5C0,Annexin,ANXA5,22.9,21.5,21.4
A0A5F5Y7J8,Annexin,ANXA5,17.6,14.8,15.2
A0A337SBJ0,Annexin,ANXA5,21.4,18.4,17
A0A337SF88,Annexin,ANXA6,23.2,20.1,20.7
A0A5F5XRH7,Annexin,ANXA6,23.1,21.3,21.3
A0A2I2UN04,Annexin,ANXA7,23.2,22.1,22.2
A0A2I2U0U5,Amine oxidase (EC 1.4.3.-),AOC2,14.9,15.2,15.7
A0A337SWK3,Amine oxidase (EC 1.4.3.-),AOC3,23.6,22,21.9
A0A2I2U7C2,Adaptor related protein complex 1 subunit beta 1,AP1B1,18.7,15.3,12.7
A0A337SCH1,Amyloid beta protein binding family B member 1,APBB1 HPX,27.7,32.3,32.3
A0A5F5XCW1,Amyloid beta protein binding family B member 1,APBB1 HPX,26.5,31.1,31.1
M3W2J4,Amyloid beta protein binding family B member 1,APBB1 HPX,25.3,29.2,29
A0A5F5XQY3,Amyloid beta like protein 1,APLP1,21.8,18.4,18.9
A0A2I2UM58,Amyloid beta like protein 2,APLP2,24,21.5,21.8
A0A337S837,Apolipoprotein A-I (Apolipoprotein A1),APOA1,27.4,33.1,33.4
M3WPG6,Apolipoprotein A-I (Apolipoprotein A1),APOA1,23.7,30.1,30.4
M3W955,Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4),APOA4,25.1,28.7,29.1
A0A337SHX7,Apolipoprotein B,APOB,26.6,26.2,26.2
P0DM82,Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I],APOC1,21.8,24.7,24.8
M3WNX1,Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2),APOC2,21.7,26.5,26.4
M3WSC8,Apolipoprotein C-III (Apolipoprotein C3),APOC3,23.6,30,30
M3W2V3,Apolipoprotein C-IV (Apolipoprotein C4),APOC4,13.5,23.6,23.6
M3X8P7,Apolipoprotein D (Apo-D),APOD,23.8,27,27.2
A0A5F5XHD8,Beta-2-glycoprotein 1 (Apolipoprotein H) (Beta-2-glycoprotein I),APOH,27.2,30.5,30.5
A0A5F5XPI7,Beta-2-glycoprotein 1 (Apolipoprotein H) (Beta-2-glycoprotein I),APOH,27.3,26.5,26.7
A0A2I2U3L7,Apolipoprotein M,APOM,22.8,27,27.2
M3W828,Apolipoprotein M,APOM,20.1,24.5,24.8
A0A0A0MPX8,Amyloid-beta A4 protein,APP,24.8,20.5,21
A0A2I2UMH4,Adenine phosphoribosyltransferase (EC 2.4.2.7),APRT,19.8,20.5,20.4
A0A2I2UAM6,Aquaporin-1 (Aquaporin-CHIP) (Water channel protein for red blood cells and kidney proximal tubule),AQP1,22.8,18,17.7
A0A2I2U5A2,Aquaporin-2 (ADH water channel) (Aquaporin-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct),AQP2,23.3,20.6,20.1
M3VUM2,Amphiregulin,AREG,20.7,16.9,17.9
A0A2I2U8Y1,ADP-ribosylation factor 3,ARF3,21.3,18.9,18.7
M3VXU3,Arginase (EC 3.5.3.1),ARG1,17.1,15.3,15.4
A0A2I2UBL3,Rho GDP-dissociation inhibitor 1 (Rho-GDI alpha),ARHGDIA,21.8,18.7,19.1
A0A2I2UL98,Rho GDP dissociation inhibitor beta,ARHGDIB,14,15,13.8
M3WSL5,Actin-related protein 2/3 complex subunit 4,ARPC4,18.6,16.7,17
M3WMY0,Actin-related protein 2/3 complex subunit 5,ARPC5,17.9,17.2,17
M3XEH2,Arrestin domain containing 1,ARRDC1,22.5,19.5,19.3
A0A5F5Y690,Arrestin domain containing 1,ARRDC1,20.9,19.3,18.9
M3WDK2,Arylsulfatase A,ARSA,23.8,19.7,19.9
A0A5F5XKR0,Arylsulfatase G,ARSG,19,20.2,18.5
M3XAU5,NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase),ART1,22.7,19.8,19.6
A0A2I2UC45,NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase),ART3,22.3,21.1,21.2
M3XDK8,NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase),ART4,24,19.7,19.4
A0A2I2V0N3,Acid ceramidase (EC 3.5.1.23),ASAH1,29,21,21.3
A0A5F5XFU3,Ankyrin repeat and SOCS box containing 1,ASB1,16.8,21.8,21.8
A0A337SSG0,Asialoglycoprotein receptor 1,ASGR1,19,16.3,16.2
A0A337SX21,Asialoglycoprotein receptor 1,ASGR1,19.9,12.2,13.1
A0A337SAN3,Asialoglycoprotein receptor 1,ASGR1,20,13.6,15
A0A2I2U788,Argininosuccinate lyase,ASL,20.6,21.6,21.9
M3WLS9,Aspartate dehydrogenase domain-containing protein,ASPDH,21.6,20.8,20.6
M3WWN6,Asporin,ASPN,20.6,17.6,17
M3W3H5,Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase),ASS1,20.7,18.4,19.2
M3W551,Copper transport protein ATOX1 (Metal transport protein ATX1),ATOX1,27.1,19.9,20.2
A0A2I2UGY1,Sodium/potassium-transporting ATPase subunit alpha,ATP1A1,24.5,20.6,20.8
M3WB86,Sodium/potassium-transporting ATPase subunit beta,ATP1B1,24.3,25,24.7
M3WZB0,ATP synthase subunit alpha,ATP5F1A,19.4,20.3,19.5
M3WF16,ATPase H+ transporting accessory protein 1,ATP6AP1,22.1,14.8,13.5
A0A337SFQ2,Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (Renin/prorenin receptor),ATP6AP2,23.2,23.1,22.8
A0A2I2UMK7,V-type proton ATPase subunit a,ATP6V0A1,18.5,16.7,17.7
A0A5F5XUE7,V-type proton ATPase proteolipid subunit,ATP6V0C,18,14.5,14.6
A0A337SG88,V-type proton ATPase subunit,ATP6V0D1,20,19.8,19.1
A0A2I2U1C8,H(+)-transporting two-sector ATPase (EC 7.1.2.2),ATP6V1A,23,21.4,21.4
A0A2I2V4V3,Vacuolar proton pump subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B),ATP6V1B2,23,21.7,22.1
A0A337SKQ1,V-type proton ATPase subunit C,ATP6V1C1,19.7,18.3,18.9
A0A337SK67,V-type proton ATPase subunit E 1 (V-type proton ATPase subunit e 1) (Vacuolar proton pump subunit E 1),ATP6V1E1,20.2,17.3,16.8
A0A2I2V0F1,V-type proton ATPase subunit G,ATP6V1G1,19.4,12.6,13.1
A0A337SHV5,V-type proton ATPase subunit H,ATP6V1H,17.5,15.9,17.5
A0A337SFT2,Attractin,ATRN,27.1,26.6,26.9
A0A2I2U5X4,Arginine vasopressin,AVP,19.6,13.1,13.2
A0A2I2UTQ4,receptor protein-tyrosine kinase (EC 2.7.10.1),AXL,25.9,20.9,20.5
Q5MGS7,Beta-2-microglobulin,B2M,26.3,21.5,21.5
M3WAQ7,Hexosyltransferase (EC 2.4.1.-),B3GNT2,24.5,22.4,22.6
A0A2I2UH51,"Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-)",B4GALT1,22.7,20.5,21
A0A5F5XM71,"Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-)",B4GALT5,21.3,18.2,18.3
M3WQ57,"Beta-1,4-glucuronyltransferase 1 (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)",B4GAT1,25.7,23.8,24.3
A0A2I2V0L4,Brain-specific angiogenesis inhibitor 1-associated protein 2,BAIAP2,21,19.9,19.9
A0A5F5XSY0,BAR/IMD domain containing adaptor protein 2 like 1,BAIAP2L1,20.3,22.5,22.7
A0A337S942,BMP and activin membrane-bound inhibitor homolog,BAMBI,23.1,21.4,17.1
A0A337STZ5,Brain abundant membrane attached signal protein 1,BASP1,19.7,21,20.4
M3W2U8,Basal cell adhesion molecule (Lutheran blood group),BCAM,26.9,21.7,22
A0A2I2UQE2,Branched-chain-amino-acid aminotransferase (EC 2.6.1.42),BCAT1,17.3,18.9,19.2
A0A2I2U2A7,BCL6 corepressor like 1,BCORL1,12.1,14.7,14.8
A0A5F5XI01,Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.104) (EC 1.1.1.30) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (4-oxo-L-proline reductase) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1),BDH2,20.8,19,19.6
A0A5F5XF81,Osteocalcin,BGLAP,19.1,13.9,14.6
A0A2I2UZ39,Bridging integrator 1,BIN1,20.3,18.2,18.1
A0A337SQ46,Biliverdin reductase B,BLVRB,24.1,20.5,22
M3VVW0,Biliverdin reductase B,BLVRB,20.1,20,21.2
M3XCQ9,receptor protein serine/threonine kinase (EC 2.7.11.30),BMPR1A,16.3,13.9,16.1
A0A2I2U0V3,receptor protein serine/threonine kinase (EC 2.7.11.30),BMPR2,21.5,18.1,18.1
M3VUA4,"BOC cell adhesion associated, onco regulated",BOC,16,20.6,21.3
M3WM50,BPI fold-containing family A member 1 (Palate lung and nasal epithelium clone protein),BPIFA1,21.7,22.6,21
A0A2I2UYJ3,Bactericidal permeability-increasing protein (BPI),BPIFC,14.9,16.1,15.6
A0A5F5XJH2,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),BROX,22.1,21.3,20.3
A0A5F5XRG8,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),BROX,21.8,18.4,18.6
A0A337S935,Bromodomain and WD repeat domain containing 1,BRWD1,14.1,18.9,17.3
A0A5F5XCB9,Basigin,BSG,24.8,20.6,20.8
A0A2I2UA49,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.6),BST1,24.1,20.1,20.1
A0A2I2U769,Bone marrow stromal cell antigen 2,BST2,20.7,21.9,22.3
A0A2I2U4L9,Biotinidase (EC 3.5.1.12),BTD,24.8,24.4,24.3
A0A337SAQ9,B and T lymphocyte associated,BTLA,20.7,18.2,18.3
A0A2I2V139,Chromosome 19 open reading frame 33,C19orf33,17.5,20.1,18.1
M3WS63,Complement C1q subcomponent subunit A,C1QA,23.7,23.9,23.9
A0A337SJG7,Complement C1q C chain,C1QC,18.9,24.3,24.4
A0A5F5XD66,C1q and TNF related 5,C1QTNF5,18.5,12.8,13.7
A0A337SDE6,complement subcomponent C1r (EC 3.4.21.41),C1R,24.1,24.5,25.5
A0A337S217,CUB domain-containing protein,C1R,19.2,24.1,25.1
A0A5F5XHF5,Complement C1s,C1S,22.2,25.8,26.4
A0A2I2V4P2,Complement C2 (EC 3.4.21.43) (C3/C5 convertase),C2,25.6,25.4,25.5
A0A5F5Y0X6,Complement component 4 binding protein alpha,C4BPA,23.9,25.4,25.4
A0A5F5Y5F1,Complement component 4 binding protein alpha,C4BPA,19.6,21.5,20.3
M3WJK3,Complement component 4 binding protein alpha,C4BPA,21.8,24,23.8
A0A5F5Y442,Complement component 4 binding protein alpha,C4BPA,23.1,25.5,25.4
M3WJK2,Complement component 4 binding protein beta,C4BPB,20.6,21,20.9
M3VV58,Complement C5,C5,24.3,26.2,26.2
M3WLH3,Complement component C6,C6,23,23.2,23.2
A0A5F5XTG9,Complement C7,C7,26.4,27,27.5
A0A5F5XPJ5,Complement C8 alpha chain,C8A,24.5,25,25.4
M3W158,Complement C8 alpha chain,C8A,15.8,16.7,17.5
A0A2I2U5W5,Complement component C8 beta chain (Complement component 8 subunit beta),C8B,22.9,25.9,26.2
M3VUN7,Complement C8 gamma chain,C8G,21.8,24.7,25.2
M3WI95,Complement component C9,C9,24.1,27.2,27.4
A0A2I2U5V0,Carbonic anhydrase (EC 4.2.1.1),CA12,23.9,20.7,21
A0A5F5XSK3,Carbonic anhydrase 14,CA14,21.2,26.2,26.4
A0A5F5Y3X9,carbonic anhydrase (EC 4.2.1.1),CA15,21.4,20.3,20.1
M3WTZ2,Chromosome A1 C5orf15 homolog,CA1H5orf15,21.4,20.8,21.8
A0A5F5XMJ0,Carbonic anhydrase (EC 4.2.1.1),CA2,25.8,24.3,25.3
M3WS40,Carbonic anhydrase (EC 4.2.1.1),CA3,25,20,20.3
M3WAR8,Carbonic anhydrase (EC 4.2.1.1),CA4,24.4,19.5,19.4
A0A2I2U448,Calcium binding protein 39,CAB39,20.3,18.4,18.7
M3WKE5,Calcium binding protein 39 like,CAB39L,19.3,16.2,16.7
A0A2I2U2E0,Calcium voltage-gated channel auxiliary subunit alpha2delta 1,CACNA2D1,24.8,27.2,26.2
A0A2I2UR43,Cell adhesion molecule 1,CADM1,23.6,18.3,18.2
A0A2I2UUH5,Cell adhesion molecule 2,CADM2,20.9,22.5,22.2
M3WMA2,Cell adhesion molecule 3,CADM3,24.2,20.1,20.6
A0A2I2ULF8,Cell adhesion molecule 4,CADM4,26.8,19.1,19.4
A0A337RZZ8,Calbindin,CALB1,19.4,18,18.2
A0A337SVD2,EF-hand domain-containing protein,CALM1,21.6,19.2,19.8
A0A337SJA7,Calmodulin 2 (Calmodulin 3),CALM3 CALM2,20,17.8,17.9
M3VUU7,Calreticulin,CALR,23.8,24.6,24
A0A2I2U8F6,Calreticulin,CALR3,22.8,22.3,23.1
A0A2I2U457,Calumenin,CALU,21.3,18.8,19.7
A0A2I2UC97,Calumenin,CALU,19.1,19.3,19
F1C962,Cathelicidin,CAMP,30.1,25.6,25.7
A0A2I2U679,Galectin-3-binding protein (Lectin galactoside-binding soluble 3-binding protein),CANT1,28.8,21.5,21.7
A0A2I2U787,Adenylyl cyclase-associated protein,CAP2,19.5,12.9,11.6
M3XEV5,Calpain 7,CAPN7,23.1,23.8,22.1
M3WK60,Calpain small subunit 1,CAPNS1,15.5,18.6,17
A0M8S9,F-actin-capping protein subunit alpha-2 (CapZ alpha-2),CAPZA2,19.7,11.7,12.2
A0A337S7D7,F-actin-capping protein subunit beta,CAPZB,19.3,16.1,16.6
A0A5F5XBX1,CASK interacting protein 1,CASKIN1,10.9,20,19.9
M3X6G1,Caveolae associated protein 1,CAVIN1,19.7,15.5,15.6
A0A337S4Q8,Chromosome B4 C12orf56 homolog,CB4H12orf56,22.6,16.6,16.9
M3W7W5,Cobalamin binding intrinsic factor,CBLIF,20.2,20.3,19.8
A0A337S4U7,Cerebellin 2,CBLN2,18.4,15.5,16.6
A0A337SFW3,Coiled-coil domain containing 126,CCDC126,18.2,17.4,17.5
A0A2I2U794,Coiled-coil domain containing 150,CCDC150,17,14.4,14.6
A0A2I2U1I0,Coiled-coil domain containing 154,CCDC154,20.3,20.6,20.5
M3WGB1,Coiled-coil domain containing 68,CCDC68,16.3,16.6,17.8
M3WCI9,C-C motif chemokine,CCL16,19.7,22.6,22.1
M3WX79,CCN family member 1 (Cellular communication network factor 1) (Protein CYR61),CCN1,21.4,19,19.2
A0A337S566,CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor),CCN2,24.7,19.9,20.8
A0A2I2UV24,CCN family member 3 (Cellular communication network factor 3),CCN3,27.5,18.5,19.2
A0A337SGQ6,Cellular communication network factor 4,CCN4,22.1,17.7,17.2
A0A337S736,T-complex protein 1 subunit delta,CCT4,15.1,13.8,13.4
A0A337SB54,CD109 molecule,CD109,26.9,17.9,18.6
M3VWC6,Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein),CD14,24,24.3,24.2
M3VZG5,CD163 molecule,CD163,22.2,22.6,22.8
A0A2I2UYP6,CD177 molecule,CD177,20.9,18.6,19.5
A0A337SMM1,Prostate androgen-regulated mucin-like protein 1,CD1H11orf24,18.2,16.3,16.2
A0A2I2U7D8,Chromosome D1 C11orf54 homolog,CD1H11orf54,23.4,21.9,22
M3W8D8,CD200 molecule,CD200,21.3,16.5,16.1
A0A5F5XNG4,CD248 molecule,CD248,27.1,20.2,20.6
A0A5F5Y5L0,CD27 molecule,CD27,22.2,13.9,14.7
A0A2I2UYF4,CD276 molecule,CD276,22,17.4,17.9
M3XCH2,CD2 associated protein,CD2AP,17,14.3,15.9
A0A337S6R6,CD300 molecule like family member g,CD300LG,25.9,18.4,18.7
A0A5F5Y2H9,CD34 molecule,CD34,21.7,16.9,16.4
A0A337S4N5,Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (CD40L receptor),CD40,19.2,16.3,17.1
A0A2I2UH63,CD44 antigen (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (Phagocytic glycoprotein I),CD44,28,20.9,20.9
A0A337SX28,Leukocyte surface antigen CD47 (Integrin-associated protein),CD47,17.8,16.6,16.4
A0A5F5XDA0,CD58 molecule,CD58,18.9,14,12.7
A0A5F5XQT8,MAC-inhibitory protein (Membrane attack complex inhibition factor) (Protectin),CD59,32.4,20.7,20.8
A0A1E1GEV5,CD5 antigen-like,cd5l AIM,18.6,22.2,21.4
A0A1E1GEW8,CD5 antigen-like,cd5l AIM,17.8,16.9,15.9
Q76B49,CD63 antigen (CD antigen CD63),CD63,20.9,22.8,23.8
A0A2I2UTM6,CD69 molecule,CD69,20.1,15.6,15.1
A0A5F5XTX9,CD80 molecule,CD80,23,20.4,21.1
A0A337S8U6,CD81 molecule,CD81,19,10.1,10.2
A0A337SBU9,Tetraspanin,CD82,20.4,17.8,17.1
A0A337S2I4,CD84 molecule,CD84,23.8,18.8,19
P40239,CD9 antigen (CD antigen CD9),CD9,20.9,18.6,19.2
A0A5F5XPS6,CD93 molecule,CD93,21.6,21.5,21.6
A0A337S9J3,CD99 antigen-like protein 2,CD99L2,22.7,18.3,17.5
A0A337SRW5,Cell division control protein 42 homolog (EC 3.6.5.2),CDC42,21.7,23.2,22.9
A0A5F5XFC6,Cell division cycle 5 like,CDC5L,21.7,21.1,21.3
A0A337SG59,Cadherin-1 (Epithelial cadherin),CDH1,24.4,19.2,19.6
A0A337S5G0,Cadherin-1 (Epithelial cadherin),CDH1,29.8,23.3,23
M3W046,Cadherin 11,CDH11,26.2,21.4,20.8
A0A337SUI1,Cadherin 13,CDH13,26.2,20.9,21.3
A0A337ST48,Cadherin 13,CDH13,27.5,20.8,23.1
A0A5F5XXK1,Cadherin 15,CDH15,22.3,19.9,19.7
A0A337S9Q3,Cadherin 16,CDH16,24.6,22.3,21
A0A5F5Y2W6,Cadherin 17,CDH17,21.1,18.3,17.9
A0A337SSN3,Cadherin 19,CDH19,23.8,20.6,20.2
A0A2I2U9W3,Cadherin-2 (Neural cadherin),CDH2,25.9,25,24.8
A0A337SEZ0,Cadherin 24,CDH24,21.6,15.9,15.6
A0A2I2UB75,Cadherin 3,CDH3,20.5,15.9,16.2
A0A337SGU2,Cadherin-4,CDH4,19.1,16.8,17.1
M3WM81,Cadherin-5 (Vascular endothelial cadherin),CDH5,16,16.5,15.9
A0A337SJ76,Cadherin domain-containing protein,CDH5,21.5,20.5,20.8
A0A337S9H7,Cadherin-6,CDH6,22.7,20.8,21.5
M3VUL6,Cadherin-6,CDH6,17.6,19.3,19.2
A0A2I2USA1,Cadherin 8,CDH8,21.9,18.7,18.8
M3VX11,Cadherin-related family member 1 (Photoreceptor cadherin) (Protocadherin-21),CDHR1,22.5,20.3,19.9
M3VZN4,Cadherin related family member 2,CDHR2,22.8,21.2,21.5
A0A5F5XIV3,Cadherin related family member 5,CDHR5,25.3,22.1,22.8
A0A5F5Y466,Cadherin related family member 5,CDHR5,23.9,16.4,17.4
A0A2I2V2G8,"Cell adhesion associated, onco regulated",CDON,17.5,18.7,17.1
M3X143,Corneodesmosin,CDSN,23,11.4,11.2
A0A5F5Y101,Corneodesmosin,CDSN,28.3,18.6,19
M3WSX6,Chromosome E3 C16orf89 homolog,CE3H16orf89,15.3,15.7,15.5
A0A337S2C9,Ig-like domain-containing protein,CEACAM1,21.9,15.7,14.8
A0A337RVE0,"CEA cell adhesion molecule 16, tectorial membrane component",CEACAM16,20.8,18.4,18.6
M3VUF8,CEA cell adhesion molecule 19,CEACAM19,22.5,14.8,16
M3X096,Carboxylic ester hydrolase (EC 3.1.1.-),CEL,22.6,23.7,23.9
Q5R1M5,Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1),CELA1 ELA1 ELS1,23.9,19.2,19.2
M3X2X6,Centromere protein C,CENPC,21.2,21.4,21.3
M3W105,Carboxylic ester hydrolase (EC 3.1.1.-),CES2,27.4,25.9,25.8
A0A337SQR3,Carboxylic ester hydrolase (EC 3.1.1.-),CES4A,16,14.6,14.7
A0A2I2UFP6,Carboxylic ester hydrolase (EC 3.1.1.-),CES5A CES1,31,22.5,24.6
M3WKH4,Carboxylic ester hydrolase (EC 3.1.1.-),CES5A CES1,20.9,19.5,18.7
Q8I034,Carboxylesterase 5A (EC 3.1.1.1) (Carboxylesterase-like urinary excreted protein) (Cauxin),CES5A CES7,34.4,22.4,23.1
M3W2B8,Complement factor B (EC 3.4.21.47) (C3/C5 convertase),CFB,28,29.8,30
A0A337SQJ3,Complement factor D (EC 3.4.21.46) (Adipsin) (C3 convertase activator) (Properdin factor D),CFD,23.1,23.2,23.1
M3XG35,Complement factor H related 5,CFHR5,21,21.2,21.3
A0A2I2U350,Complement factor I,CFI,24.5,27.5,27.6
M3WIJ6,"Cofilin-1 (Cofilin, non-muscle isoform)",CFL1,22.7,20.6,20.5
A0A337SEF0,Cofilin-2,CFL2,22.8,18.6,19
M3W950,Complement factor properdin,CFP,19.5,23.8,23.6
Q52R91,Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain),CGA,18.1,10.8,10.7
A0A5F5XGZ4,Cingulin like 1,CGNL1,25.8,26.9,27.2
A0A337SFJ9,Chromogranin-A,CHGA,19.5,12.7,11.9
A0A5F5XCZ2,Chromogranin-A,CHGA,21,11,10.7
A0A2I2UDB3,Chitinase-3-like protein 1,CHI3L1,19.5,17.6,17.7
A0A337SU79,Cell adhesion molecule L1 like,CHL1,17.8,18.6,18.7
M3W0W8,Charged multivesicular body protein 2a (Chromatin-modifying protein 2a),CHMP2A,22.8,17.8,18
A0A337S8C4,Charged multivesicular body protein 2B,CHMP2B,19.6,14,15.8
A0A5F5Y7M8,Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein sorting-associated protein 24),CHMP3,18.9,19.5,18.9
M3WXJ4,Charged multivesicular body protein 4B,CHMP4B,22.7,20.5,20.8
M3X6F1,Charged multivesicular body protein 5 (Chromatin-modifying protein 5),CHMP5,20.2,13.5,12.6
A0A337SL92,Charged multivesicular body protein 5 (Chromatin-modifying protein 5),CHMP5,22,18.9,18.8
A0A337SGE0,Chondrolectin,CHODL,23.6,19,19.9
M3WI48,Sulfotransferase (EC 2.8.2.-),CHST3,19.2,17.1,16.9
M3WF53,Cartilage intermediate layer protein,CILP,21.9,19.3,19.7
M3WKI3,Cartilage intermediate layer protein 2,CILP2,26.7,22.7,22.4
A0A2I2UED7,Cytoplasmic linker associated protein 1,CLASP1,15.2,15.5,14.2
A0A2I2U6F0,C-type lectin domain containing 11A,CLEC11A,22.7,22.2,22.1
M3VWY2,C-type lectin domain family 4 member G,CLEC4G,21,19.1,18.7
A0A2I2UE55,C-type lectin domain containing 7A,CLEC7A,22,22.7,23
A0A337SW69,C-type lectin domain containing 7A,CLEC7A,19.8,15,14.9
M3WNY6,Chloride intracellular channel protein,CLIC1,21.9,20.5,20.6
A0A337SD38,Chloride intracellular channel protein,CLIC4,23.7,21.1,21.1
A0A2I2UVX8,Chloride intracellular channel protein,CLIC5,19.1,16.2,16.1
M3VW19,CXADR like membrane protein,CLMP,20.6,18.1,17.1
A0A2I2U499,Battenin,CLN3,17.7,20.4,22.3
A0A2I2UWU9,CLN5 intracellular trafficking protein,CLN5,23.3,19.2,18.8
M3W2V0,Apolipoprotein E,CLPTM1 APOE,24.1,25.7,25.9
A0A337S9Y3,Apolipoprotein E,CLPTM1 APOE,24.1,24.3,24.8
M3VU87,Calsyntenin-3,CLSTN3,21.3,20.7,20.3
M3WKP2,Clusterin,CLU,23.3,23.9,23.9
A0A5F5XGP3,Clusterin,CLU,29,29.4,29.3
A0A5F5XKE9,Cytidine/uridine monophosphate kinase 2,CMPK2,22.2,19.9,21.6
A0A337SUS1,Carnosine dipeptidase 2,CNDP2,23.3,21.7,20.8
M3W9A2,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Threonyl dipeptidase),CNDP2,22.6,19.1,19.1
A0A337SGM0,Metal transporter,CNNM4 CNNM3,20.3,15.8,16.9
M3WWG3,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",CNP,19.1,19.4,19.2
A0A337RVG5,Ciliary neurotrophic factor receptor subunit alpha,CNTFR,23.2,21.2,21
A0A2I2U968,Contactin-1,CNTN1,21.3,18.8,19.2
A0A2I2UN28,Cochlin,COCH,28.8,17,17.2
M3WFG2,Cochlin,COCH,18,15.3,15.6
A0A337S496,Collagen type XI alpha 1 chain,COL11A1,21.7,17.7,17.3
A0A2I2U432,Collagen type XII alpha 1 chain,COL12A1,27.3,23.7,23.5
A0A337RZD5,Collagen type XIV alpha 1 chain,COL14A1,23.6,22,21.8
A0A337RV83,Collagen type XV alpha 1 chain,COL15A1,25.8,22.3,22
A0A5F5XC75,Collagen type XVIII alpha 1 chain,COL18A1,25.2,21.3,21.6
M3W2F5,Collagen type I alpha 1 chain,COL1A1,23.1,17.5,17.9
A0A5F5XYM1,Collagen type I alpha 2 chain,COL1A2,23.1,18.3,19.3
M3WVN3,Collagen type I alpha 2 chain,COL1A2,20.9,17.1,16.9
M3WPE0,Collagen type XXVIII alpha 1 chain,COL28A1,21.5,11.7,11.3
A0A5F5Y1B8,Collagen type III alpha 1 chain,COL3A1,24.2,20.9,20.4
A0A5F5Y4J4,Collagen type IV alpha 1 chain,COL4A1,19.7,17.3,17.3
A0A5F5XGS9,Collagen type IV alpha 2 chain,COL4A2,23.3,20.1,20.3
A0A337RYM9,Collagen type IV alpha 3 chain,COL4A3,20.3,18.3,18.8
A0A337SN04,Collagen type IV alpha 5 chain,COL4A5,21.4,21,19.5
A0A2I2UD65,Collagen type V alpha 2 chain,COL5A2,25.8,25.2,23.5
A0A5F5XGI4,Collagen type V alpha 3 chain,COL5A3,23.3,18.7,18.8
M3WLD9,Collagen type VI alpha 1 chain,COL6A1,20.7,19.2,19
A0A2I2U2C4,Collagen type VI alpha 2 chain,COL6A2,21.9,19.3,19.1
A0A337S4V9,Collagen type VI alpha 3 chain,COL6A3,27.7,21.2,21.3
A0A337RW59,Collagen type VI alpha 3 chain,COL6A3,27.1,24.4,24.6
M3WHG4,Collagen type VI alpha 3 chain,COL6A3,24.5,19.2,18.7
A0A2I2U7G3,Collagen type VIII alpha 1 chain,COL8A1,19.8,16.2,16.3
A0A2I2UH03,Collectin subfamily member 10,COLEC10,17.5,18.4,18.7
A0A2I2U3V7,Collectin-11,COLEC11,20.6,20.9,21.4
A0A2I2U1P2,Collectin-12,COLEC12,27.3,22.2,23.9
M3WN82,Collectin-12,COLEC12,18.7,15.3,15.3
A0A5F5XKH5,Cartilage oligomeric matrix protein,COMP,17.1,16.1,15.2
A0A337S2A4,Cartilage oligomeric matrix protein,COMP,23.2,21.9,22.6
M3VWP9,Coatomer subunit beta',COPB2,21.7,19,17.7
A0A337RVF9,ADF-H domain-containing protein,COTL1,25.5,22.5,22
A0A2I2U8E4,ferroxidase (EC 1.16.3.1),CP,27.8,28.4,28.9
A0A5F5XZM2,Carboxypeptidase A1,CPA1,24.7,22.3,22.5
M3WKB7,Carboxypeptidase A1 (EC 3.4.17.1),CPA1,23.4,20.5,20.7
A0A2I2U0Y4,Carboxypeptidase B (EC 3.4.17.2),CPB1,23,19.6,19.5
A0A2I2UAE6,Carboxypeptidase B2,CPB2,23.8,24.4,24.6
A0A337SN31,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D),CPD,20.6,20.4,19.7
M3WGH2,Carboxypeptidase E (EC 3.4.17.10) (Carboxypeptidase H) (Enkephalin convertase) (Prohormone-processing carboxypeptidase),CPE,23.4,23.8,24.4
M3WMF1,Carboxypeptidase N subunit 2,CPN2,24.7,26.3,26.4
A0A2I2V326,Copine 1,CPNE1,21.7,17.7,17.8
A0A337SJW2,Copine 3,CPNE3,24.4,21.5,21.6
A0A2I2U0K1,Copine 4,CPNE4,22.5,17.3,17.7
A0A337SEH6,"Carboxypeptidase X, M14 family member 2",CPXM2,18.8,18.1,15.9
U5TLB4,CPXV028 protein,CPXV028,21,20.7,20.8
A0A0K2YWB3,CPXV211 protein,CPXV211,18.5,17,16.5
A0A337SSG2,Carboxypeptidase Z,CPZ,20.4,16.4,18.6
A0A337SJR3,Complement C3d receptor 2,CR2,20.6,17.8,18.1
A0A337SV16,Crumbs cell polarity complex component 1,CRB1,21.5,15.6,16
A0A337SRL8,Crumbs cell polarity complex component 2,CRB2,24.6,23.2,23.7
A0A5F5XYI6,Cyclic AMP-responsive element-binding protein 3-like protein 2,CREB3L2,15,14.2,15.5
M3WK50,cAMP responsive element binding protein 3 like 3,CREB3L3,23.8,20.4,21
A0A5F5XJY1,Cellular repressor of E1A stimulateds 1,CREG1,22,19.7,20.4
A0A337S172,Cysteine rich transmembrane BMP regulator 1,CRIM1,21.9,19.5,18.7
M3WNB8,Cysteine rich protein 1,CRIP1,17.5,16.6,15.4
A0A2I2UC81,Cysteine rich secretory protein 3,CRISP3,29.5,19.6,19.7
A0A5F5XVE8,Cysteine rich secretory protein 3,CRISP3,16,18.9,18.3
A0A5F5Y1N6,Cysteine rich secretory protein 3,CRISP3,13,18.9,18.4
A0A337SBA6,Adapter molecule crk,CRK,22.3,21.1,20.1
M3W544,"CRK like proto-oncogene, adaptor protein",CRKL,16.3,16,16.4
A0A5F5XWB9,Pentraxin family member,CRP,26.7,27.3,27
A0A2I2UDI7,Cartilage acidic protein 1,CRTAC1,27.2,22,21.8
A0A5F5XI25,L-gulonate 3-dehydrogenase (EC 1.1.1.45) (L-gulonate 3-dehydrogenase),CRYL1,21.6,18,18.4
A0A5F5XUR3,Ketimine reductase mu-crystallin (EC 1.5.1.25) (NADP-regulated thyroid-hormone-binding protein),CRYM,16.7,13.7,13.7
A0A337SVX9,Crystallin zeta,CRYZ,18.9,19.2,18.6
A0A337SMK6,Colony stimulating factor 1,CSF1,22.6,20.1,21
P13369,Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115),CSF1R FMS,18.1,13.6,13.1
M3WGW7,Chondroitin sulfate proteoglycan 4,CSPG4,26.2,20.7,20.6
D5MTH1,Cystatin C,CST3,23,20.7,21
M3WIK5,Cystatin E/M,CST6,27.4,21.1,20.9
Q8WNR9,Cystatin-A (allergen Fel d 3),CSTA,21.5,18,17.6
A0A337SE08,Cystatin domain-containing protein,CSTB,21.5,16.5,16.8
A0A337SJE3,Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase),CTH,24.2,22.9,22
A0A337SHY2,Collagen triple helix repeat containing 1,CTHRC1,21.4,20.7,20.2
A0A2I2U5B1,Catenin beta-1 (Beta-catenin),CTNNB1,18.6,17.5,17.9
A0A5F5XDM8,Chymotrypsin C,CTRC,25.7,20.6,20.7
M3W019,Chymotrypsin C,CTRC,24.1,17.2,18.4
M3WHR1,Chymotrypsin like,CTRL,22.7,20,20.7
A0A337SMR1,Carboxypeptidase (EC 3.4.16.-),CTSA,23.5,22,21.6
M3WLU0,Cathepsin B (EC 3.4.22.1),CTSB,25.2,22.7,23.1
M3W9M0,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (Dipeptidyl transferase),CTSC,25.2,21.5,21.4
M3W8G3,Cathepsin D (EC 3.4.23.5),CTSD,26,20.9,21.2
M3W7M8,Cathepsin F,CTSF,20.8,19.1,18.9
M3WGI2,Pro-cathepsin H,CTSH,20.5,13.8,14
A0A337SUC3,Pro-cathepsin H,CTSH,21.6,19.7,19.7
M3W0Q2,Cathepsin K (EC 3.4.22.38),CTSK,18.3,18.9,19.1
M3WUC1,Cathepsin O,CTSO,21.8,18.9,17.9
A0A337RZ12,Cathepsin S,CTSS,25,20.2,20
M3W0Q1,Cathepsin S (EC 3.4.22.27),CTSS,23.9,18.1,17.9
A0A5F5XBP7,cathepsin X (EC 3.4.18.1),CTSZ,26.1,19.7,18.9
M3VVI7,cathepsin X (EC 3.4.18.1),CTSZ,25.5,20.1,18.5
M3WJ25,Cubilin,CUBN,29.2,25.7,25.6
A0A2I2UJG2,CutA divalent cation tolerance homolog,CUTA,20,15.2,15.7
A0A2I2UQ66,CXADR Ig-like cell adhesion molecule,CXADR,24.2,20.8,20.8
O62657,Stromal cell-derived factor 1 (SDF-1) (C-X-C motif chemokine 12),CXCL12 SDF1,22.1,19.4,20.5
M3WSR7,C-X-C motif chemokine 16 (Transmembrane chemokine CXCL16),CXCL16,22,18.5,18.1
M3VWB9,Cysteine-rich and transmembrane domain-containing protein 1,CYSTM1,22,20,19.9
A0A337S6Y2,DAB adaptor protein 2,DAB2,22,19.9,19.2
A0A337SFQ4,Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1),DAG1,23.7,22,22.2
A0A2I2U6R0,Acyl-CoA-binding protein,DBI,22.1,16.2,17.1
A0A337SMV2,"Discoidin, CUB and LCCL domain containing 2",DCBLD2,22.8,18,18
A0A337S0Q6,Decorin (Bone proteoglycan II),DCN,20.1,16.5,16.5
M3WFI7,L-xylulose reductase (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase),DCXR,19.7,16.3,16.4
A0A2I2U3S0,Dimethylarginine dimethylaminohydrolase 1,DDAH1,22.6,20.1,19.7
M3XC02,Dimethylarginine dimethylaminohydrolase 2,DDAH2,26,23.8,23.2
A0A337SE70,receptor protein-tyrosine kinase (EC 2.7.10.1),DDR1,24.1,21.8,22
A0A2I2UUM4,"Beta-defensin 1 (Defensin, beta 1)",DEFB1,25.8,17.2,16.6
A0A337S785,"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.1.1.179) (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (Dimeric dihydrodiol dehydrogenase)",DHDH,25.8,23,23.4
A0A337SIN6,Delta like non-canonical Notch ligand 1,DLK1,22.2,16.4,16.1
A0A2I2U119,Delta like non-canonical Notch ligand 1,DLK1,23.7,17.1,17
M3X710,Delta like non-canonical Notch ligand 2,DLK2,23.9,20.9,21.3
M3W5T1,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (E2K)",DLST,23.2,18.9,19.3
A0A5F5XLL3,Dermokine,DMKN,19.6,14.3,12.8
A0A5F5XE39,Dermokine,DMKN,21.9,18.4,18.5
A0A337S6Z7,Dentin matrix acidic phosphoprotein 1,DMP1,16.4,10.2,10.3
A0A5F5XJC4,Dynein axonemal heavy chain 11,DNAH11,24,23.2,23.1
A0A5F5XEB8,Dynein axonemal heavy chain 8,DNAH8,21.7,21,20.7
A0A337S1A5,DnaJ heat shock protein family (Hsp40) member C11,DNAJC11,17.9,18.9,18.3
A0A5F5XF61,DnaJ heat shock protein family (Hsp40) member C28,DNAJC28,16.6,19.3,18
M3WGM9,Deoxyribonuclease,DNASE1,30.8,20.9,22.8
A0A2I2UNJ5,Deoxyribonuclease 1 like 2,DNASE1L2,22.3,17.7,17.9
M3VUU5,Deoxyribonuclease-2-alpha (EC 3.1.22.1) (Acid DNase) (Deoxyribonuclease II alpha) (Lysosomal DNase II),DNASE2,24.3,19.2,19.1
A0A5F5XGS4,Docking protein 7,DOK7,21.9,16.5,17
M3W0Z1,Dipeptidase (EC 3.4.13.19),DPEP1,24.6,22.6,22.2
A0A337S046,Dipeptidyl peptidase like 10,DPP10,16.2,12.9,11.8
Q9N2I7,Dipeptidyl peptidase 4 (EC 3.4.14.5) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)],DPP4 CD26,29,22,21.5
A0A5F5XVS8,Dipeptidyl peptidase 7,DPP7,25.6,21,21.3
M3XE34,Dermatopontin,DPT,28.9,20.3,20.1
A0A2I2U844,Dihydropyrimidinase,DPYS,23.5,19.9,20
A0A5F5XFR8,Dihydropyrimidinase,DPYS,21,17.8,18.6
A0A2I2UZA9,Desmocollin 1,DSC1,25.2,19.9,19.5
A0A2I2UGD4,Desmocollin 2,DSC2,24.8,24.2,24.4
A0A2I2UCR1,Desmocollin 2,DSC2,21.5,19.7,19.6
A0A337SP25,Desmoglein 1,DSG1,21.5,19,18.4
M3WCK3,Desmoplakin,DSP,22.6,22.9,21.2
A0A2I2UFE0,Destrin (Actin-depolymerizing factor),DSTN,21.4,16.7,16.2
M3WM59,"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase)",ECHS1,18.8,18.1,17.9
M3W858,Enoyl-CoA delta isomerase 1,ECI1,15.7,15.3,15.4
M3WRY2,Extracellular matrix protein 1,ECM1,25.1,27.4,26.3
A0A337SPQ5,Ectodysplasin A receptor,EDAR,20,16.9,17.8
A0A337SND7,Endothelin-3 (Preproendothelin-3),EDN3,22.4,14.5,15
A0A337SDI4,Endothelin receptor type B (Endothelin receptor non-selective type),EDNRB,17.5,17,16
A0A2I2U0I8,Early endosome antigen 1,EEA1,22.1,16.8,17
Q66RN5,Elongation factor 1-alpha 1 (EF-1-alpha-1) (EC 3.6.5.-) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1),EEF1A1 EEF1A,24.8,24.7,24.4
M3W2D2,EF-hand calcium binding domain 14,EFCAB14,16.9,16.8,18.1
M3VVE6,EGF containing fibulin extracellular matrix protein 1,EFEMP1,28.2,25.5,25.3
A0A337SCW7,EGF containing fibulin extracellular matrix protein 2,EFEMP2,24.6,22.9,23
A0A337SFI6,Elongation factor like GTPase 1,EFL1,19.3,19.4,19.6
A0A337S356,Ephrin-A1,EFNA1,26.3,17.8,18.3
A0A337SBN3,Ephrin A4,EFNA4,23.6,18.1,18.3
A0A337S0H8,EPH-related receptor tyrosine kinase ligand 7,EFNA5,20.2,22.2,21.7
M3WR70,Ephrin-B1,EFNB1,24.4,22.8,21.1
B0LDS5,Ephrin-B2,efnB2,24.7,22.6,21.9
A0A337SFQ1,Ephrin B3,EFNB3,22.9,22.2,19.3
Q95ND4,Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor],EGF,30.2,24.3,23.9
A0A2I2U1L8,Pro-epidermal growth factor,EGF,20.5,13.9,13.9
A0A0P0GH12,receptor protein-tyrosine kinase (EC 2.7.10.1),EGFR,18.9,18.9,18.4
A0A337S424,Receptor protein-tyrosine kinase (EC 2.7.10.1),EGFR,20.2,22.5,22.4
M3X1U0,EH domain containing 1,EHD1,22.5,22.4,22.2
M3WXE7,EH domain containing 4,EHD4,20.6,19.6,20
A0A5F5XQI4,Choline transporter-like protein,EHMT2,20.7,17.5,16.1
A0A2I2UKH0,Choline transporter-like protein,EHMT2,17.2,15.8,16.3
M3XDI4,Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Hemin-sensitive initiation factor 2-alpha kinase),EIF2AK1,20,20.8,20.8
M3WCG8,Translation initiation factor eIF2B subunit gamma (eIF2B GDP-GTP exchange factor subunit gamma),EIF2B3,23.2,19,19
A0A2I2U322,Eukaryotic translation initiation factor 4 gamma 3,EIF4G3,18.2,19,18.1
A0A5F5XCL3,Eukaryotic translation initiation factor 5,EIF5,19,14.8,14.5
A0A337RZ59,Eukaryotic translation initiation factor 5A-1 (Eukaryotic initiation factor 5A isoform 1) (eIF-4D),EIF5A,17.8,14.4,16.1
M3W5W5,Eukaryotic translation initiation factor 6 (eIF-6),EIF6 ITGB4BP,24.7,20.6,21.3
M3XDQ5,"Elastase, neutrophil expressed",ELANE,17.3,13.1,14.5
A0A5F5XSQ0,"Elastase, neutrophil expressed",ELANE,25.1,16.8,17.7
A0A2I2UVP6,EMAP like 5,EML5,21.5,18,18.6
M3XGC9,Endonuclease domain containing 1,ENDOD1,21.2,20.2,20.2
A0A2I2UTE6,phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO1,22.1,19.5,19.4
A0A337S0P1,phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO1,18.9,12.4,12.4
A0A2I2UHT3,phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO2,20.4,17.2,17.6
A0A2I2UJ14,Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (Skeletal muscle enolase),ENO3,21.9,19.6,20
A0A2I2V5H4,Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO4,20.7,16,17.4
M3VU18,Aminopeptidase (EC 3.4.11.-),ENPEP,25.6,21.1,21.5
A0A2I2V3L7,Ectonucleotide pyrophosphatase/phosphodiesterase 2,ENPP2,22,20.8,21.1
A0A2I2V568,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (EC 3.1.4.1) (EC 3.6.1.9) (Phosphodiesterase I beta) (Phosphodiesterase I/nucleotide pyrophosphatase 3),ENPP3,24,21.5,21.6
A0A2I2U6N9,bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4),ENPP4,17.9,10.1,10
M3X1B4,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,ENPP5,20.3,21.3,21.4
M3VWW1,glycerophosphocholine cholinephosphodiesterase (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6),ENPP6,23.9,20.1,20.1
P11261,Envelope glycoprotein (Env polyprotein) [Cleaved into: Surface protein (SU) (Glycoprotein 70) (gp70); Transmembrane protein (TM) (Envelope protein p15E); R-peptide (p2E)],env,20.5,20.6,20.4
A0A0D5ZXZ6,Env protein,env,12.5,11.8,10.6
M3WIV4,Epithelial cell adhesion molecule (Tumor-associated calcium signal transducer 1),EPCAM,23.2,19.8,20.2
A0A5F5XZT1,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA1,24.8,20.5,20.5
A0A2I2UHA0,EPH receptor A10,EPHA10,18.3,13.7,12.3
A0A2I2UV62,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA4,21.7,18.5,18.5
A0A2I2UTP3,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA5,21,10,10.3
A0A5F5XNL0,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA7,23.4,20.6,19.7
M3WPK6,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA7,23.4,14.2,14
A0A337RY03,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHB1,19,14.8,14.3
A0A2I2UI65,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHB2,23.4,21.4,19.9
A0A5F5Y2L8,Ephrin type-B receptor 3 (EC 2.7.10.1),EPHB3,23.7,20.1,19.5
A0A2I2V293,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHB4,24.6,23.4,22.9
A0A5F5XXF9,EPH receptor B6,EPHB6,25.8,21.7,21.4
M3WSY6,Epidermal growth factor receptor pathway substrate 8,EPS8,23,21.2,21.8
M3X4X2,EPS8 like 1,EPS8L1,19.1,15,17.3
A0A2I2UQW0,Aminopeptidase (EC 3.4.11.-),ERAP1,19.9,19.4,19.2
M3WVD3,Epiregulin,EREG,18.2,17.1,14
M3VV12,ER lipid raft associated 1,ERLIN1,23.9,24.1,24.1
A0A5F5XI42,Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1),ERLIN1,16.5,22.1,22.1
M3WMZ2,Endoplasmic reticulum protein 44,ERP44,21.6,19.2,19.6
A0A2I2V4V9,Endothelial cell adhesion molecule,ESAM,25,21,20.3
M3XAF3,S-formylglutathione hydrolase (EC 3.1.2.12),ESD,20.2,16.3,16.8
A0A2I2UQQ2,Eva-1 homolog C,EVA1C,19.4,19.6,19.1
M3XFW7,Ribosomal RNA-processing protein 42,EXOSC7,22.1,27.4,27.4
A0A337S6A6,Exostosin like glycosyltransferase 2,EXTL2,18.8,21.8,21.8
A0A337S6P4,Exostosin like glycosyltransferase 2,EXTL2,20,22,21.8
A0A2I2U6X9,Ezrin (Cytovillin) (Villin-2) (p81),EZR,26.2,26.8,26.3
M3WKC7,Coagulation factor X (EC 3.4.21.6) (Stuart factor),F10,22.2,26.2,26
Q2WGK2,Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (CD antigen CD321),F11R JAM1,28.1,21,21.1
A0A1W7HNZ6,Coagulation factor XII (EC 3.4.21.38) (Hageman factor),F12,23.4,26,25.7
A0A2I2U5J7,Coagulation factor XIII A chain,F13A1,23.7,24.8,24
A0A5F5XF87,Coagulation factor XIII B chain,F13B,23,24.7,24.2
M3WSI8,Prothrombin (EC 3.4.21.5) (Coagulation factor II),F2,29.8,29.1,29.2
M3W050,Proteinase-activated receptor 1 (Thrombin receptor),F2R,21.5,17.6,18.3
A0A337SQW4,Coagulation factor V,F5,24.5,24.7,26.7
M3W922,Coagulation factor V,F5,19.5,19.6,20.6
M3WKC6,Coagulation factor VII (EC 3.4.21.21) (Serum prothrombin conversion accelerator),F7,20.2,22.3,22.3
A0A5F5XH53,Coagulation factor VIII,F8,22.3,21,20.8
Q6SA95,Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain],F9,23.3,25.2,24.9
M3WR74,"Fatty acid-binding protein, liver (L-FABP) (Liver-type fatty acid-binding protein)",FABP1,19.6,18.2,18.2
A0A5F5XG15,Fatty acid binding protein 2,FABP2,23.9,17.8,18.6
M3WQY4,"Fatty acid-binding protein, intestinal (Fatty acid-binding protein 2) (Intestinal-type fatty acid-binding protein)",FABP2,18.8,16.8,16
M3X9Z0,"Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein)",FABP3,24.2,21.4,20.6
A0A5F5XIT1,Fatty acid binding protein 5,FABP5,17.7,14.5,14.1
A0A5F5XFP7,Fumarylacetoacetase (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase),FAH,21.6,19.8,20.9
M3W1C3,Protein FAM151A,FAM151A,25.6,23.2,21.7
A0A337RY82,Family with sequence similarity 174 member B,FAM174B,18.1,15.2,14.5
A0A337RZ83,FAM20C golgi associated secretory pathway kinase,FAM20C,21,20.7,21
A0A5F5XGS1,Family with sequence similarity 234 member A,FAM234A,20.3,17.2,17.8
A0A5F5Y0R2,Family with sequence similarity 234 member A,FAM234A,18.6,12.4,13.3
A0A337S9Y1,FAM3 metabolism regulating signaling molecule B,FAM3B,21.9,16.5,17
A0A2I2UZV7,Protein FAM3C,FAM3C,22.6,21.4,20.2
A0A2I2U2C0,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor),FAS,19.4,18.3,18.2
M3WFK0,Fatty acid synthase (EC 1.1.1.100) (EC 1.3.1.39) (EC 2.3.1.38) (EC 2.3.1.39) (EC 2.3.1.41) (EC 2.3.1.85) (EC 3.1.2.14) (EC 4.2.1.59),FASN,25.2,23.6,23.4
A0A2I2UCL3,FAT atypical cadherin 4,FAT4,22.7,21.7,21.9
A0A337SRF9,Fibulin-1,FBLN1,27.2,24.1,23.9
M3WZ15,Fibulin-1,FBLN1,23.2,24,23.1
A0A2I2UFJ4,Fibulin 2,FBLN2,24.6,20.4,20.4
A0A337S164,Fibulin-5,FBLN5,27.4,23.3,22.9
A0A337SXC1,Fibulin 7,FBLN7,23.8,16.1,15.1
A0A337S7Y7,Fibulin 7,FBLN7,27,20.9,21.4
M3WMG2,Fibrillin 1,FBN1,27.4,23.3,23.4
M3WB78,"Fructose-1,6-bisphosphatase 1 (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",FBP1,24.5,22.1,22.3
M3VXP7,"Fructose-1,6-bisphosphatase isozyme 2 (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)",FBP2,18.8,17.4,17.7
A0A5F5Y0F7,Fc epsilon receptor II,FCER2,24.5,25.7,25.1
A0A2I2UDZ7,VWFD domain-containing protein,FCGBP,22.3,21.9,18.8
A0A5F5Y6R9,Fc gamma receptor Ia,FCGR1A,16.1,14.1,13.1
Q9N2I5,Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (Fc-gamma RIII-alpha) (FcgammaRIIIA) (CD antigen CD16a),FCGR3A CD16,23.7,21,22.1
A0A337S1R1,Fc mu receptor,FCMR,17.4,19.3,19.2
M3X177,Fem-1 homolog A,FEM1A,13.3,17.3,17.3
A0A5F5XXG1,Fer-1 like family member 6,FER1L6,17.1,14.1,15.4
A0A337RZH0,Fetuin B,FETUB,24.1,26.6,26.6
P14450,Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A],FGA,16.3,25.5,17.3
M3W022,Fibrinogen alpha chain,FGA,27.3,32,25.1
P14469,Fibrinogen beta chain [Cleaved into: Fibrinopeptide B],FGB,22.8,25.7,19.5
M3WII3,Fibrinogen beta chain,FGB,24.5,31.9,24.4
A0A5F5XVE3,"FYVE, RhoGEF and PH domain containing 3",FGD3,23.7,23.8,23.9
A0A2I2UK29,Fibroblast growth factor receptor (EC 2.7.10.1),FGFR1,25.2,21.8,22.1
A0A337S7G1,Fibroblast growth factor receptor (EC 2.7.10.1),FGFR3,20.9,17.2,17.2
A0A5F5XGZ0,Fibrinogen gamma chain,FGG,24.1,31.2,23
A0A5F5XLT1,Fibrinogen gamma chain,FGG,11.6,20.3,10.4
A0A516V1E7,MHC class I antigen,FLA-E,15.2,12.1,11.1
A0A516V1E1,MHC class I antigen,FLA-E,16.2,15.5,16.9
A0A516V164,MHC class I antigen,FLAI-E,22.7,20.1,19.7
S4Z3G3,MHC class I antigen,FLAI-E,13,15,15.4
A0A516V168,MHC class I antigen,FLAI-H,21.8,21.1,20.8
A0A516V172,MHC class I antigen,FLAI-H,15.5,13.6,12.9
A0A516V166,MHC class I antigen,FLAI-H,21.6,19.2,19
A0A516V181,MHC class I antigen,FLAI-H,15.2,14.1,13
A0A516V177,MHC class I antigen,FLAI-H,15.2,14.1,13
A0A516V1A6,MHC class I antigen,FLAI-K,17.9,18,17.4
A0A337SDQ4,"Saoe class I histocompatibility antigen, A alpha chain-like",FLAI-K,19.7,14,14.1
A0A2I2V3V8,Filamin A,FLNA,26,22.8,22.5
A0A2I2US09,Filamin B,FLNB,25.5,21.2,21.3
A0A2I2UDN6,Filamin C,FLNC,24.7,20.3,19.8
M3X0B9,Fibronectin leucine rich transmembrane protein 2,FLRT2,18.9,16.2,16.4
A0A2I2UES4,Vascular endothelial growth factor receptor 3 (EC 2.7.10.1),FLT4,18.2,20.2,20.1
A0A2I2U011,Fibronectin,FN1,29.5,27.9,27.5
A0A2I2UAM2,Fibronectin,FN1,18.5,20.9,20.5
A0A5F5XFC0,Fibronectin type III domain containing 1,FNDC1,16.4,14.3,17.1
A0A337SB41,Folate hydrolase 1,FOLH1,19.1,17.1,16.5
M3WR11,Folate receptor alpha,FOLR1,26.4,20.1,20.2
M3XEV8,Ferric chelate reductase 1,FRRS1,21.7,20.4,20.6
A0A2I2V2F6,Secreted frizzled-related protein 3 (Frizzled-related protein 1) (FrzB-1),FRZB,22.3,19,18.9
M3WL17,Follitropin subunit beta (Follicle-stimulating hormone beta subunit) (Follitropin beta chain),FSHB,23.8,26.9,26.8
A0A337S130,Follistatin-related protein 1 (Follistatin-like protein 1),FSTL1,25.6,21,20.9
A0A2I2U6V1,Follistatin like 3,FSTL3,20.3,17.9,18.2
Q2MHN1,Ferritin light chain (Ferritin L subunit),FTL,21.8,21.2,20.6
A0A060PNW6,Thrombomodulin,fTM,23.3,17.7,18.3
A0A337S4I1,Alpha-L-fucosidase 1,FUCA1,23.9,19.7,20.2
M3W912,Alpha-L-fucosidase (EC 3.2.1.51),FUCA2,20,12.9,13.1
A0A5F5XT00,alpha-L-fucosidase (EC 3.2.1.51),FUCA2,21.4,21.9,22.5
A0A5F5XZJ7,furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme),FURIN,24.1,23.5,24
M3X4M3,Frizzled-1,FZD1,20.7,21.8,19.7
M3X1P3,Frizzled-2,FZD2,14.8,15.8,15.1
A0A2I2UH80,Frizzled-4,FZD4,22.7,17.3,19
M3W3B8,Frizzled-6,FZD6,22.8,16.1,16
A0A2I2U7V2,Frizzled class receptor 7,FZD7,23.6,18.5,19.3
A0A5F5XKV2,Frizzled class receptor 8,FZD8,21.4,15.7,15.7
A0A5F5XIY0,Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase),GAA,27.2,22.9,23.3
A0A5F5XGF8,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,18.7,24.3,24.5
A0A2I2U122,Galactose-3-O-sulfotransferase 1,GAL3ST1,24.3,24.5,25.2
M3X9U2,Galactose-3-O-sulfotransferase 4,GAL3ST4,20.3,13.2,12.7
A0A2I2UQ95,Galactocerebrosidase (EC 3.2.1.46) (Galactosylceramidase),GALC,20.2,16.2,16.9
A0A5F5Y4N4,Galactosamine (N-acetyl)-6-sulfatase,GALNS,21.8,18.4,17.7
A0A5F5XTD3,Galactosamine (N-acetyl)-6-sulfatase,GALNS,24.5,22.3,22.3
A0A5F5Y2N0,Polypeptide N-acetylgalactosaminyltransferase (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase),GALNT18,22.2,23.2,22.7
A0A2I2UA27,Glucosidase II alpha subunit,GANAB,21.2,20.6,20.7
Q9N2D5,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-),GAPDH GAPD,24.4,19.8,20.9
A0A5F5XUR6,Growth arrest specific 1,GAS1,25.3,17,16.8
A0A5F5XGA1,Growth arrest specific 6,GAS6,26.5,22.2,21.6
A0A5F5XDS7,Golgi associated kinase 1A,GASK1A,17,18,18.4
M3VVL7,Glucosylceramidase (EC 3.2.1.45),GBA1,19.6,20.3,20
A0A337SNL3,Glucosylceramidase (EC 3.2.1.45),GBA1,21.7,19.8,21.4
A0A2I2UCJ0,Glucosylceramidase beta 3,GBA3,21.6,18.6,18.3
M3W2Z1,Vitamin D-binding protein (Gc-globulin) (Group-specific component),GC,27.5,32.1,32
A0A2I2U4I8,Growth differentiation factor 10,GDF10,18,19.5,19.5
A0A337S915,Rab GDP dissociation inhibitor,GDI2,23.5,21.8,22.3
M3WHB4,Rab GDP dissociation inhibitor,GDI2,20.3,19.5,19.4
A0A337SH50,Glycerophosphodiester phosphodiesterase domain containing 2,GDPD2,20.8,18.3,19.1
A0A5F5XDL4,Glycerophosphodiester phosphodiesterase domain containing 3,GDPD3,19.4,17.8,17
A0A2I2UI95,Glial fibrillary acidic protein,GFAP,21.1,19.3,19.6
A0A337SD81,GDNF family receptor alpha 1,GFRA1,20.9,17.5,17.6
A0A2I2UFV4,GDNF family receptor alpha-2 (GDNF receptor alpha-2),GFRA2,23.1,22.1,22.2
M3WQ38,Gamma-glutamylaminecyclotransferase (EC 4.3.2.8),GGACT,24.5,19.6,19.7
A0A5F5XWZ9,folate gamma-glutamyl hydrolase (EC 3.4.19.9),GGH,23.7,20.2,20.4
M3VWS9,Glutathione hydrolase (EC 2.3.2.2) (EC 3.4.19.13) (Gamma-glutamyltransferase) (Gamma-glutamyltranspeptidase),GGT1,25.9,23.6,25.5
A0A2I2UZ31,Gamma-glutamyltransferase 6,GGT6,17.8,16.7,17.2
M3WEU6,Glycosylated integral membrane protein 1,GINM1,21.8,20.4,21
A0A2I2UF05,GIPC PDZ domain containing family member 2,GIPC2,15.6,13.3,12.7
M3W803,Gastrokine 1,GKN1,14.8,16.9,17.3
A0A2I2U1V5,Alpha-galactosidase (EC 3.2.1.-),GLA,26.2,21.9,22.6
O19015,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),GLB1 BGAL,25.3,22.6,21.2
A0A2I2URA0,Golgi apparatus protein 1,GLG1,24.7,22.4,22.7
A0A2I2U855,GLI pathogenesis related 2,GLIPR2,16.8,19.3,19.7
A0A5F5XL86,Lactoylglutathione lyase (EC 4.4.1.5) (Glyoxalase I),GLO1,19.6,19.2,18.7
M3X3M9,Glutaredoxin-1,GLRX,19.4,19.5,18.6
M3WHT1,Ganglioside GM2 activator,GM2A,29.2,21.3,21.5
A0A337S5X4,Guanine nucleotide-binding protein subunit alpha-11,GNA11,20.6,15.8,16.1
A0A2I2UZP1,G protein subunit alpha 13,GNA13,22.5,17.3,17.3
A0A2I2U673,Guanine nucleotide-binding protein G(i) subunit alpha-3 (G(i) alpha-3),GNAI3,23.6,22.2,23
A0A2I2U651,Guanine nucleotide-binding protein G(o) subunit alpha,GNAO1,19.2,15.9,15.4
A0A2I2U1S9,G protein subunit alpha transducin 3,GNAT3,22.5,17.3,17.3
M3WU86,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1),GNB1,22.8,20.2,19.6
M3X5T9,G protein subunit beta 2,GNB2,20.7,19,19
A0A2I2U2P0,G protein subunit beta 4,GNB4,22.3,18.4,19.4
A0A2I2UXE2,Guanine nucleotide-binding protein subunit gamma,GNG12,20.4,20.2,22
A0A5F5XZA0,N-acetylglucosamine-1-phosphate transferase subunit gamma,GNPTG,20.9,20.4,19.9
M3VUR6,N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase),GNS,27.5,20.8,21.2
A0A5F5XP94,Golgi membrane protein 1,GOLM1,25.6,29.2,29.5
M3WCA0,Golgi membrane protein 1,GOLM1,22.1,18.7,19
A0A5F5XGH7,Aspartate aminotransferase (EC 2.6.1.1),GOT1,23.3,24.9,25.5
A0A5F5XIK0,Glycoprotein Ib platelet subunit alpha,GP1BA,26.2,22.9,23.2
A0A5F5XJV1,Glycoprotein 2,GP2,19.4,17.9,18.2
A0A2I2U027,Glycoprotein V platelet,GP5,22.2,21.6,21.2
M3WSF8,Immunoglobulin subtype domain-containing protein,GP6,21.6,18.9,17.3
A0A2I2U6L5,Glypican-1,GPC1,24.4,20.2,22
A0A337S4V2,Glypican-3,GPC3,18.4,17.3,17.5
A0A5F5XH67,Glypican 4,GPC4,23.1,19.8,19.6
M3WBH7,Glycerol-3-phosphate dehydrogenase [NAD(+)] (EC 1.1.1.8),GPD1,23,20.7,20.4
A0A337S9I7,Glucose-6-phosphate isomerase (EC 5.3.1.9),GPI,21.3,18.8,18.6
A0A337ST09,Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1,GPIHBP1,19.4,19.6,19.5
A0A5F5XQW6,Phosphatidylinositol-glycan-specific phospholipase D (EC 3.1.4.50) (Glycosyl-phosphatidylinositol-specific phospholipase D),GPLD1,24.2,26.6,27.1
A0A5F5XTB2,Phosphatidylinositol-glycan-specific phospholipase D (EC 3.1.4.50) (Glycosyl-phosphatidylinositol-specific phospholipase D),GPLD1,21.9,25,25.2
A0A337S764,Neuronal membrane glycoprotein M6-a,GPM6A,20.9,21.2,20.9
A0A2I2UBJ4,Glycoprotein M6B,GPM6B,16.6,16.1,15.5
A0A5F5XQN9,G protein-coupled receptor 108,GPR108,21.9,26.1,26.1
M3WUB8,G protein-coupled receptor 180,GPR180,21.1,19.5,19.6
A0A2I2UTY3,G protein-coupled receptor 37,GPR37,18.8,15.8,14.7
A0A2I2UB41,G protein-coupled receptor class C group 5 member B,GPRC5B,20.1,17.4,17.6
A0A2I2UI30,G protein-coupled receptor class C group 5 member C,GPRC5C,26,19.7,20
A0A2I2UII4,Glutathione peroxidase,GPX1,19.2,18,19.2
A0A2I2V5E5,Glutathione peroxidase,GPX3,21.9,28.3,28.2
A0A5F5XWC4,Glutamate receptor,GRIA4,22.9,23.1,23.1
A0A5F5XTI2,Granulin,GRN,22.1,18.4,18.2
A0A2I2V346,Granulin,GRN,23.8,19.3,19.9
A0A2I2UTS2,Gelsolin (ADF) (Actin-depolymerizing factor),GSN,26.8,28.1,28.5
A0A337SJ23,Glutathione synthetase (GSH-S) (EC 6.3.2.3),GSS,19.4,16.7,17.7
A0A337SLL9,Glutathione S-transferase omega (GSTO) (EC 1.20.4.2) (EC 1.8.5.1) (EC 2.5.1.18) (Glutathione-dependent dehydroascorbate reductase) (Monomethylarsonic acid reductase),GSTO1,20.3,17.4,18.1
A0A2I2U8R6,glutathione transferase (EC 2.5.1.18) (GST class-pi),GSTP1,22.5,17.7,18.7
A0A2I2UUQ5,maleylacetoacetate isomerase (EC 5.2.1.2),GSTZ1,24,24.4,24.5
M3W5G2,Guanylin (Guanylate cyclase activator 2A),GUCA2A,21.6,19.5,19.8
A0A5F5XR95,Guanylate cyclase activator 2B,GUCA2B,16.8,12.4,11.7
M3W5G1,Guanylate cyclase activator 2B,GUCA2B,19,15.3,16.1
O97524,Beta-glucuronidase (EC 3.2.1.31),GUSB,26.5,20.9,20.9
A0A5F5XKM9,"H1.4 linker histone, cluster member",H1-4,22.8,18.8,18.6
A0A337S2X4,Histone H2A,H2AC14,16.9,16.5,16.3
A0A2I2U2D3,Histone H2A,H2AZ1,23.2,18.5,19.8
A0A2I2USF3,Histone H2B,H2BC17,20.9,18.5,17.7
A0A2I2UIG2,Histone H3,H3C5,23.4,25.2,23.4
M3WSM7,Histone H4,H4C4 H4C1 H4C11 H4C12 H4C13 H4C14 H4C19 H4C2 H4C3 H4C6 H4C8 H4C9 LOC123385657,22.7,18.3,18.1
A0A2I2UIZ2,Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase,H6PD,23.4,24.5,25
M3VUF1,"3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6) (3-hydroxyanthranilate oxygenase) (3-HAO) (3-hydroxyanthranilic acid dioxygenase) (HAD)",HAAO,29.5,24,23.4
A0A5F5Y062,Hyaluronan binding protein 2,HABP2,21.4,25.3,25.3
M3WFU5,Hyaluronan binding protein 2,HABP2,16.7,22.5,22.3
A0A2I2U3V1,3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35),HADH,21.1,20.8,20.9
A0A2I2UQN2,"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II)",HAGH,18.1,17.3,17.9
A0A2I2UFL9,Hepcidin antimicrobial peptide,HAMP,24.6,11,11.2
A0A024A8A5,Hepatitis A virus cellular receptor 1 variant A,HAVCR1,22.3,22.8,22.4
P07405,Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain) [Cleaved into: Hemopressin],HBA,24.8,29,30.2
P07412,Hemoglobin subunit beta-A/B (Beta-A/B-globin) (Hemoglobin beta-A/B chain),HBB,26.1,30.4,31.7
A0A2I2U9B2,Tyrosine-protein kinase (EC 2.7.10.2),HCK,19.5,16.7,16.5
M3W3P5,Hyperpolarization activated cyclic nucleotide gated potassium channel 4,HCN4,25.8,16.4,15.9
A0A337S0K9,E3 ubiquitin-protein ligase (EC 2.3.2.26),HECTD1,15.9,21.8,13.5
M3WLX7,Heart development protein with EGF like domains 1,HEG1,25.6,20.6,20.9
G4XSV9,Beta-hexosaminidase (EC 3.2.1.52),HEXA,26.1,20.6,20.5
P49614,Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta),HEXB,25.4,24.1,24.3
M3WHB2,HGF activator,HGFAC,24,26.7,26.6
A0A337SUG1,Hemojuvelin BMP co-receptor,HJV,21.6,19.1,19.4
M3X1M2,Hemicentin 1,HMCN1,25.8,19.8,19.8
M3X7U8,Hemicentin 2,HMCN2,25.5,21.4,21.6
A0A2I2UVJ9,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,16.7,12.8,10.8
A0A2I2UI32,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,17.5,16.5,16.4
A0A5F5XGD0,Haptoglobin,HP,30.6,32.2,32.4
A0A5F5XBX6,4-hydroxyphenylpyruvate dioxygenase,HPD,22.2,22.9,22.7
A0A5F5Y3T3,4-hydroxyphenylpyruvate dioxygenase,HPD,19.7,16.9,17
A0A2I2UDC4,Hepsin,HPN,22.7,18.8,18.8
M3WJM9,Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein),HRG,24.4,26.3,26.4
A0A337S6T1,Heat shock protein HSP 90-alpha,HSP90AA1,19.7,19.7,20.1
A0A2I2U7X4,Heat shock protein HSP 90-beta,HSP90AB1,23.3,21.5,20.9
A0A5F5XWD4,Endoplasmin (94 kDa glucose-regulated protein) (Heat shock protein 90 kDa beta member 1),HSP90B1,19.1,16.4,16.5
M3X6Z7,Heat shock 70 kDa protein 13 (Stress-70 protein chaperone microsome-associated 60 kDa protein),HSPA13,23,20.6,21.3
M3WFT4,78 kDa glucose-regulated protein (Binding-immunoglobulin protein) (Heat shock protein 70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),HSPA5,24,22.2,22.3
A0A2I2UZM2,Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8),HSPA8,25.2,22.6,22.5
A0A5F5XK17,Heat shock protein family B (small) member 1,HSPB1,21.3,17.1,16.7
M3WXZ4,"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (Heat shock protein 60)",HSPD1,19.8,17.4,18.6
A0A337SEI8,"10 kDa heat shock protein, mitochondrial (10 kDa chaperonin) (Chaperonin 10)",HSPE1,20.2,17.8,17
A0A5F5Y6R8,Heparan sulfate proteoglycan 2,HSPG2,30.1,24.5,24.8
M3W0Q9,HtrA serine peptidase 1,HTRA1,22.5,17.1,17.9
M3WMB7,HtrA serine peptidase 3,HTRA3,19.5,18.9,19.7
M3VYS9,HtrA serine peptidase 4,HTRA4,20.5,14,13.6
A0A337SAA4,Hyaluronidase (EC 3.2.1.35),HYAL2,21.6,19.6,19.7
A0A5F5XBM7,Putative hydroxypyruvate isomerase (EC 5.3.1.22),HYI,22.6,21.1,21.2
A0A337SRM7,Intercellular adhesion molecule 1,ICAM1,22,22.1,22.3
M3WBF1,Intercellular adhesion molecule 1,ICAM1,23.3,22.4,22.5
A0A337SJL0,Intercellular adhesion molecule 2,ICAM2,24.1,20.7,20.8
A0A337SQM4,Inducible T cell costimulator ligand,ICOSLG,23.8,20.5,21.2
M3W1B8,Isocitrate dehydrogenase [NADP] (EC 1.1.1.42),IDH1,20.6,18.6,19.5
A0A337SJX9,Iduronate 2-sulfatase,IDS,20.6,15.4,16
A0A097HWG4,Alpha-L-iduronidase (EC 3.2.1.76),IDUA,21.3,18.3,18.5
M3WSA1,Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30),IFI30,27.1,20.2,20.3
A0A2I2UFF7,Interferon alpha inducible protein 6,IFI6,18.1,16.1,15.6
M3XFG7,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Type I interferon receptor 1),IFNAR1,18.8,17.1,17.5
A0A2I2UIQ7,Insulin-like growth factor I (Somatomedin),IGF1,17,23,22.6
A0A2I2UMR3,Insulin-like growth factor II,IGF2,19.9,24,23.5
A0A5F5XQ21,Insulin like growth factor 2 receptor,IGF2R,24.5,24.1,24.2
M3VZ93,Insulin like growth factor 2 receptor,IGF2R,20.3,18.5,18.3
A0A337SDJ8,Insulin like growth factor binding protein acid labile subunit,IGFALS,24.2,26.9,26.9
M3W4L2,Insulin-like growth factor-binding protein 1,IGFBP1,26.3,20.8,20.9
A0A2I2UEZ6,Insulin-like growth factor-binding protein 2,IGFBP2,26.9,24,23.8
A0A2I2USR5,Insulin-like growth factor-binding protein 3,IGFBP3,24.8,27,26.8
A0A337RVY2,Insulin-like growth factor-binding protein 4,IGFBP4,19.4,21.3,21
A0A2I2UF06,Insulin-like growth factor-binding protein 5,IGFBP5,17.9,20.1,19.8
M3VUH9,Insulin like growth factor binding protein 6,IGFBP6,18.8,20.4,20.1
A0A2I2U3H1,Insulin like growth factor binding protein 7,IGFBP7,29.6,21.8,21.9
A0A337SLQ6,IGF like family receptor 1,IGFLR1,20.4,17.5,17.6
A0A2I2UAS8,IgLON family member 5,IGLON5,24.2,18.7,18.7
A0A2I2UBK6,Immunoglobulin superfamily member 5,IGSF5,20,18.6,17.5
A0A2I2U7U8,Immunoglobulin superfamily member 8,IGSF8,26.1,22.4,22.7
A0A2I2UF36,Interleukin 18 binding protein,IL18BP,25.9,18.6,18.8
A0A2I2UA72,Interleukin 1 receptor accessory protein,IL1RAP,26.3,25.9,26.1
A0A337SPR9,Interleukin-1,IL1RN,18.1,13.3,13.6
P41690,Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (CD antigen CD25),IL2RA,21.8,17.9,17.5
A0A2I2U0A6,Interleukin-1,IL36RN,19,15.6,13.8
A0A337S2C8,Interleukin-4 receptor subunit alpha,IL4R,20.5,13.7,13.8
M3X8X7,Interleukin 6 receptor,IL6R,21.2,18.3,19.3
A0A337S1N7,Interleukin 6 cytokine family signal transducer,IL6ST,23.4,23.2,23.6
A0A5F5XF39,Interleukin 6 cytokine family signal transducer,IL6ST,19.3,17.1,16.8
A0A337S505,Interleukin 6 cytokine family signal transducer,IL6ST,20.1,18.2,18.4
M3VZN9,Interleukin 9 receptor,IL9R,16,10,10.2
M3W832,Integrator complex subunit 1,INTS1,20.7,22.3,22.3
M3XDA8,Integrator complex subunit 4,INTS4,17.5,18.3,18.9
A0A337SRV8,Interferon regulatory factor 2 binding protein like,IRF2BPL,16.5,10.6,10.9
M3X315,Immunoglobulin superfamily containing leucine rich repeat,ISLR,26.5,22.2,22.2
A0A5F5XEF9,Isthmin 1,ISM1,17.7,12.4,11.2
A0A2I2UAK7,IST1 homolog (Charged multivesicular body protein 8),IST1,25,22.1,23.5
A0A5F5Y493,Integrin alpha FG-GAP repeat containing 1,ITFG1,23.7,23.1,22.6
A0A2I2USG0,Integrin subunit alpha 3,ITGA3,17.3,14,15.1
A0A2I2UVP7,Integrin subunit alpha 6,ITGA6,17.7,16.6,16.8
A0A5F5Y6V1,VWFA domain-containing protein,ITGAX,20,16.7,16.9
P53713,Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29),ITGB1,22.4,18.9,19.8
A0A222NT34,Integrin beta,ITGB2,19.4,15.5,13.4
M3WN59,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,25.6,27.9,28
A0A337SQW0,Inter-alpha-trypsin inhibitor heavy chain 2,ITIH2,25.2,28.7,28.8
A0A337SL30,Inter-alpha-trypsin inhibitor heavy chain 3,ITIH3,20,25.7,25.7
A0A337SEU6,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,23.4,27.1,27.1
M3WN60,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,16.2,19.9,19.3
A0A2I2U7R4,Inter-alpha-trypsin inhibitor heavy chain 4,ITIH4,26.9,29,29.3
M3WEM7,Inter-alpha-trypsin inhibitor heavy chain 5,ITIH5,26,24.1,22.4
A0A5F5XMZ9,Inter-alpha-trypsin inhibitor heavy chain 5,ITIH5,24.6,18.1,18.9
A0A2I2UVC1,Integral membrane protein 2,ITM2B,22.8,20.2,20.2
A0A2I2U9Y7,Integral membrane protein 2,ITM2C,14.4,16.2,14.4
A0A2I2U3Z6,"Isovaleryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.1) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase)",IVD,19.9,19.3,18.7
A0A2I2UBC8,Delta-like protein,JAG1,20,15.9,15.4
A0A337SEF1,Junctional adhesion molecule 3,JAM3,23.8,23.2,20.8
A0A5F5XX70,Junctional adhesion molecule 3,JAM3,22.8,19.8,19.8
A0A337SAT8,Junction adhesion molecule like,JAML,18,15.6,16.5
A0A5F5XC52,Joining chain of multimeric IgA and IgM,JCHAIN,29.3,24.3,24.5
A0A2I2UBN8,Junction plakoglobin,JUP,22.8,24.7,24.7
A0A2I2UA55,Kazal type serine peptidase inhibitor domain 1,KAZALD1,21.9,17.8,17.6
A0A337RZ36,Potassium channel tetramerization domain containing 12,KCTD12,19.5,18.2,17.6
A0A2I2UIN2,Vascular endothelial growth factor receptor 2 (EC 2.7.10.1),KDR,18.1,14.9,14.5
A0A2I2U3F2,KIAA0319 like,KIAA0319L,23.3,19.8,21.1
A0A5F5XE91,Kinesin-like protein,KIF12,32.2,27.7,27.9
A0A5F5Y533,Kinesin-like protein,KIF12,19.3,16.5,16.7
M3VU73,Kinesin-like protein,KIF12,22.4,19.5,19.6
A0A2I2U1G6,Kinesin family member 21A,KIF21A,22.7,15.9,15.2
A0A5F5XE96,Kinesin family member 26A,KIF26A,18.2,12.1,12.1
A0A337S5Y7,Kirre like nephrin family adhesion molecule 1,KIRREL1,22,20.5,20.4
A0A337RZN4,Kirre like nephrin family adhesion molecule 1,KIRREL1,17.3,17,17.7
Q28889,Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117),KIT,21.7,20.1,20.4
P79169,Kit ligand (Mast cell growth factor) (MGF) (Stem cell factor) (SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand (sKITLG)],KITLG SCF,20.4,15.2,16.2
A0A5F5XC24,Kallikrein B1,KLKB1,23.9,25.6,25.5
A0A337SQ55,Natural killer cells antigen CD94 (Killer cell lectin-like receptor subfamily D member 1),KLRD1,21.3,14.8,15.2
A0A2I2U294,Kininogen 1,KNG1,31.9,29.8,29.8
A0A5F5XVF5,Kininogen 1,KNG1,21.6,23.2,22.6
A0A2I2UHH3,small monomeric GTPase (EC 3.6.5.2),KRAS,21.3,16.1,15.9
A0A337SC09,Kremen protein (Kringle-containing protein marking the eye and the nose),KREMEN1,20.2,21.7,22.7
M3VXR1,"Keratin, type I cytoskeletal 10 (Cytokeratin-10) (Keratin-10)",KRT10,27.2,24.1,24.3
A0A337SCP9,IF rod domain-containing protein,KRT13,27.6,24.3,24.3
A0A337SM15,Keratin 17,KRT17,24.8,21.1,21.5
A0A5F5XLA0,"Keratin, type I cytoskeletal 17 (Cytokeratin-17) (Keratin-17)",KRT17,21.4,19,19.1
A0A5F5XF56,"Keratin, type I cytoskeletal 17 (Cytokeratin-17) (Keratin-17)",KRT17,20.2,19.5,19
A0A5F5Y768,Keratin 17,KRT17,20.3,21,21.1
M3VXK4,"Keratin, type I cytoskeletal 17 (Cytokeratin-17) (Keratin-17)",KRT17,19.6,20.1,19.8
M3VUH3,Keratin 18,KRT18,23.3,22.5,22.9
A0A2I2U642,"Keratin, type I cytoskeletal 20 (Cytokeratin-20) (Keratin-20)",KRT20,22.7,18.7,19.4
A0A2I2UVW3,"Keratin, type I cytoskeletal 27 (Cytokeratin-27) (Keratin-27) (Type I inner root sheath-specific keratin-K25irs3)",KRT25 KRT27,25.8,22.7,22.8
M3VUG8,Keratin 3,KRT3,24.3,21.4,21.5
M3VUE5,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (Keratin-7) (Type-II keratin Kb7)",KRT7,22.6,20.5,20.6
E1AB55,"Keratin, type II cytoskeletal 71 (Cytokeratin-71) (CK-71) (Keratin-71) (K71)",KRT71,25.2,21.5,21.8
M1RGZ2,Keratin 73,KRT73,17.9,19.4,18.4
M3VUF9,Keratin 74,KRT74,25.2,21.5,21.7
A0A337S538,Keratin 74,KRT74,24.4,20,20
M3VUG7,Keratin 76,KRT76,25.1,21.6,21.8
A0A5F5XKG5,Keratin 77,KRT77,25.6,22.7,22.7
M3WZD7,IF rod domain-containing protein,KRT89,20.5,17.5,18.4
A0A5F5XMX8,Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase),KYNU,19.4,15.3,15.7
A0A2I2U6T7,L1 cell adhesion molecule,L1CAM,23.9,23.2,23.1
A0A337SDW1,LINE1 type transposase domain containing 1,L1TD1,21.5,21.7,18.1
A0A5F5XCK9,Endoribonuclease LACTB2 (Beta-lactamase-like protein 2),LACTB2,17.8,18.6,20.6
A0A5F5XQP4,Leukocyte associated immunoglobulin like receptor 1,LAIR1,25,17.7,17.9
A0A5F5XIU1,Laminin subunit alpha 4,LAMA4,24.3,17.4,17.5
A0A5F5Y366,Laminin subunit alpha 5,LAMA5,22.3,23,24.6
M3W292,Laminin subunit beta 1,LAMB1,23.9,24.2,23.2
M3WC88,Laminin subunit beta 2,LAMB2,17.5,17,17.7
M3WXS7,Laminin subunit gamma 1,LAMC1,22.4,20.7,20.2
A0A337RYK1,Laminin subunit gamma 2,LAMC2,19.8,13.7,12.5
A7XPK6,Lysosomal associated membrane protein 1,LAMP1,19.2,17.5,17
C6GGN9,Lysosomal associated membrane protein 1 (Lysosomal-associated membrane glycoprotein 1),LAMP1 LAMP-1,24.6,20.6,21
A0A337STH0,Lysosomal associated membrane protein 2,LAMP2,28.5,22.3,22.6
A0A2I2V3S9,Lysosomal associated membrane protein 3,LAMP3,17.4,16.4,15.9
A0A5F5XSP5,Cytosol aminopeptidase (EC 3.4.11.1) (EC 3.4.11.5) (EC 3.4.13.23) (Cysteinylglycine-S-conjugate dipeptidase) (Leucine aminopeptidase 3) (Leucyl aminopeptidase) (Proline aminopeptidase) (Prolyl aminopeptidase),LAP3,22,21.4,21.1
A0A337SJA8,Layilin,LAYN,21.9,18.3,18.8
M3WXB6,Layilin,LAYN,20.6,19.6,17.9
A0A5F5Y0Z4,Lipopolysaccharide-binding protein (LBP),LBP,19.3,22.6,22.5
A0A5F5XKS1,Lipopolysaccharide-binding protein (LBP),LBP,21.2,23.2,23.3
M3XCK7,Lipocalin like 1,LCNL1,27.1,21,21.2
A0A2I2U572,Lymphocyte cytosolic protein 1,LCP1,21,20.6,19.5
A0A2I2UZG1,L-lactate dehydrogenase (EC 1.1.1.27),LDHA,21.4,17.6,17.7
A0A337S8L1,L-lactate dehydrogenase (EC 1.1.1.27),LDHA,20.3,17.2,17.8
A0A2I2U9C6,L-lactate dehydrogenase (EC 1.1.1.27),LDHB,24,20,19.9
A0A2I2U4Z0,L-lactate dehydrogenase (EC 1.1.1.27),LDHC,21.9,15.7,16.3
A0A337SRL4,Low-density lipoprotein receptor,LDLR,22,18.8,18.1
A0A2I2UMV3,Liver-expressed antimicrobial peptide 2,LEAP2,25.6,19.7,19.8
A0A5F5XUA4,Leukocyte cell derived chemotaxin 2,LECT2,15.1,17.6,16.7
M3WKX0,Leukocyte cell derived chemotaxin 2,LECT2,15.5,19.2,19.4
Q9N2C1,Leptin (Obesity factor),LEP OB,18.1,18.6,17.9
A0A337SEC0,Galectin,LGALS1,21.3,21.2,21.5
A0A337S4Q5,Galectin,LGALS3,21.9,22.4,22.3
A0A2I2U709,Galectin,LGALS9,22.8,17.9,17.9
A0A337S0D5,"Legumain (EC 3.4.22.34) (Protease, cysteine 1)",LGMN,20.5,18.8,19.2
M3W8K5,"Legumain (EC 3.4.22.34) (Protease, cysteine 1)",LGMN,20.7,14.3,14.9
A0A5F5XGD3,LIF receptor subunit alpha,LIFR,24.5,25.6,25.3
A0A5F5XPV2,Lipase,LIPA,30.4,21.1,21.2
A0A5F5XQ31,"Lectin, mannose binding 2",LMAN2,30.3,22.1,22.3
A0A5F5XTW1,Lysosomal cobalamin transport escort protein LMBD1 (LMBR1 domain-containing protein 1),LMBRD1,15,10.7,12.7
A0A5K1VP01,Lamin A/C,LMNA,24.2,12.9,12.6
M3VU75,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC100144393,28.1,29.8,29.9
E5D2Z5,Fel d 7 allergen,LOC100533977,25.8,19.5,20.6
M3WJA1,Pepsin A (EC 3.4.23.1),LOC101080826,29.8,17.5,17.5
A0A5F5XDG7,Pregnancy zone protein,LOC101080976,25.9,29.4,29.5
A0A5F5XG49,Pregnancy zone protein-like,LOC101080976,21.4,26.1,26
A0A337S803,Ovostatin homolog 2-like,LOC101081475,22.5,26.9,27
A0A2I2U8D7,C-type lectin domain-containing protein,LOC101082144,21.5,18.5,18.7
A0A2I2UMM1,Uncharacterized protein,LOC101082733,20,18.6,18.9
A0A2I2UP08,Sushi domain-containing protein,LOC101085428,23.1,27.5,27.3
M3WP64,Peptidase S1 domain-containing protein,LOC101085453,19.3,18.3,18
A0A337S8S6,Peptidase S1 domain-containing protein,LOC101085453,29.2,25.6,25.5
A0A5F5XMU9,Coiled-coil domain-containing protein 170-like,LOC101086571,18.5,19.3,19.1
A0A2I2UUI4,Cathepsin L,LOC101086605,24.1,21,20.9
A0A337SVW6,Annexin,LOC101087010,21,17.7,17.2
A0A337RWP8,Ly-6/neurotoxin-like protein 1,LOC101087710,26.1,18.8,18.7
A0A2I2UV75,Cystatin domain-containing protein,LOC101088567,21.1,17.5,17.1
A0A5F5XV52,Peptidase S1 domain-containing protein,LOC101089318,19.9,15.9,15.8
A0A2I2U4V9,Peptidase S1 domain-containing protein,LOC101089318,18.8,12.3,12.6
M3X2R3,Mesothelin,LOC101091333,24.3,21.5,21.4
A0A5F5XVL7,Sulfotransferase (EC 2.8.2.-),LOC101091370,25.1,18.8,19
A0A5F5XTD9,Sulfotransferase (EC 2.8.2.-),LOC101091370,24.2,19.6,19.3
A0A5F5XKI3,Sulfotransferase (EC 2.8.2.-),LOC101091370,22,18.5,18.6
A0A2I2UYB0,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101091569,21.9,16.5,17.1
A0A337SM43,Olfactory receptor,LOC101093693 LOC111560946,21.3,26.1,26.2
A0A337SE00,C-X-C motif chemokine,LOC101094096,21.8,24.2,26.7
A0A2I2U006,Nicotinamide N-methyltransferase,LOC101094108,19.9,14.1,12.6
A0A5F5XZS8,Peptidase S1 domain-containing protein,LOC101094275,21.9,12.3,13.1
A0A5F5XT89,Peptidase S1 domain-containing protein,LOC101094275,25.1,20.1,19.8
A0A2I2UKK1,Uncharacterized protein,LOC101094346,28.1,28.7,28.9
A0A5F5XFU6,Uncharacterized protein,LOC101094346,22.2,23.8,24
A0A2I2UT16,Albumin domain-containing protein,LOC101095098,25.1,23.8,23.8
M3WBI8,C-type lectin domain family 18 member A,LOC101095392,20.3,16,17.3
M3W3Q0,Glutathione S-transferase (EC 2.5.1.18),LOC101096317,21.1,19,16.9
A0A5F5XEY9,Butyrophilin like 9,LOC101097782,26.5,22.1,21.9
A0A2I2UXL4,Globin family profile domain-containing protein,LOC101098159,22.2,25,26.2
A0A2I2U6J8,Globin family profile domain-containing protein,LOC101098159,18.8,22.7,24.1
M3WVZ4,Globin A1,LOC101098159 GLNA1,17,20.9,20.6
A0A2I2U232,Adenylate cyclase-stimulating G alpha protein,LOC101098453,23.5,23.4,23.6
A0A2I2U5B2,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101098498,26.6,17.2,17.5
A0A2I2U227,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101098498,30.5,23.2,23.7
A0A5F5XBZ0,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101098498,21.3,17.8,18.2
A0A5F5Y107,Enoyl reductase (ER) domain-containing protein,LOC101100387,20,19.2,19.4
A0A337SQ74,IGF like family member 3,LOC101101603,23.2,18,18.7
A0A5F5XCJ2,Membrane cofactor protein,LOC102899273,24.3,14.9,15.3
A0A5F5XZ26,UPAR/Ly6 domain-containing protein,LOC102899673,26,16.4,16.7
A0A5F5XEP4,Sushi domain-containing protein,LOC102899713,16.1,21,20.7
A0A2I2UIM4,Carbonyl reductase (NADPH) (EC 1.1.1.184),LOC102901316,22.1,19.1,19.7
A0A2I2UFN2,Carbonyl reductase (NADPH) (EC 1.1.1.184),LOC102901316,12.9,14.6,15.2
A0A5F5XD04,Ig-like domain-containing protein,LOC105259618,26.4,24.3,24.9
A0A2I2U7X7,Ig-like domain-containing protein,LOC105259814,21.8,20,19.8
A0A337S014,Ig-like domain-containing protein,LOC105259814,23.7,20.4,19.9
A0A2I2UYG1,MHC class I antigen,LOC105260551,19,16.5,17.3
A0A5F5XH25,Tumor necrosis factor receptor superfamily member 1A,LOC105261012,21.8,16,17.4
A0A5F5XJG5,Immunoglobulin V-set domain-containing protein,LOC109494125,19,21.1,23
A0A5F5XI37,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC109496317,26.5,29.2,30
A0A337SF46,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC111556219,25,18.6,19.4
A0A5F5XQF5,Immunoglobulin V-set domain-containing protein,LOC111557803,20.6,17.9,17.4
A0A337S103,Metallothionein,LOC111558024,21.5,14.9,14.4
M3XB79,Metallothionein,LOC111558024,16.7,18.4,18.4
A0A2I2V287,Cathepsin L1-like,LOC111559124,22.2,14.6,14.8
A0A5F5XP31,Kazal-like domain-containing protein,LOC123379994,18.5,10,10
A0A2I2UAR3,Lysyl oxidase homolog (EC 1.4.3.13),LOX,24.4,18.5,17.9
M3WFA5,Lysyl oxidase like 1,LOXL1,19.5,19.6,20.2
M3WB92,Lysyl oxidase like 4,LOXL4,23.1,20.6,20.5
A0A337S1P2,Leucine rich alpha-2-glycoprotein 1,LRG1,28.6,26.8,26.9
M3VU91,LDL receptor related protein 1,LRP1,23.2,19.2,18.6
M3W5B5,LDL receptor related protein 2,LRP2,30.2,26.9,26.7
A0A2I2UQB6,LDL receptor related protein 2,LRP2,28.7,23.2,22.1
M3W2W3,LRP2-binding protein,LRP2BP,22.6,25,25.2
A0A5F5Y4L2,LDL receptor related protein associated protein 1,LRPAP1,21.8,20.4,20.3
M3X588,Leucine rich repeat containing 15,LRRC15,18.8,16.1,17.9
M3X167,Leucine rich repeat containing 19,LRRC19,23.5,15.7,16.2
M3W4V0,Leucine rich repeat containing 8 VRAC subunit A,LRRC8A,21.7,16.9,17
M3X2H7,Leucine rich repeat containing 8 VRAC subunit D,LRRC8D,21.7,16.9,17
A0A2I2V4D2,Leucine rich repeat neuronal 4,LRRN4,20.9,12.8,15.2
A0A2I2UKX6,Limbic system associated membrane protein,LSAMP,25.9,19.8,19.8
A0A5F5XMF4,Leucine rich single-pass membrane protein 2,LSMEM2,20.5,15.1,16
A0A5F5XBY8,Leukotriene A(4) hydrolase (LTA-4 hydrolase) (EC 3.3.2.6),LTA4H,15.3,16.1,16
A0A337S431,Latent transforming growth factor beta binding protein 1,LTBP1,25.7,20,19.7
A0A337S8E4,Latent transforming growth factor beta binding protein 1,LTBP1,20.4,14.1,14.8
A0A140CWF2,LTBP2,LTBP2,23.3,19.9,20.4
A0A2I2UXX3,Latent transforming growth factor beta binding protein 4,LTBP4,28,22.4,22.2
A0A2I2V3V6,Lactotransferrin,LTF,29.5,23.6,25.3
A0A5F5XC36,Lactotransferrin,LTF,26.2,18.2,18.5
A0A2I2U619,Lumican,LUM,20.8,23,23.2
A0A337SJ42,Lymphocyte antigen 6 family member D,LY6D,29.1,19.8,19.3
M3VTY7,LY6/PLAUR domain containing 1,LYPD1,19.1,15.9,15.9
M3VU52,LY6/PLAUR domain containing 2,LYPD2,15.8,16.1,15.6
M3WY30,LY6/PLAUR domain containing 3,LYPD3,19.2,15.9,15.4
A0A2I2U035,LY6/PLAUR domain containing 6,LYPD6,19.4,13.2,14.4
A0A2I2UP64,LY6/PLAUR domain containing 6B,LYPD6B,21.9,20.5,20.5
A0A2I2UCN9,Acyl-protein thioesterase 1 (EC 3.1.2.22) (Lysophospholipase 1) (Lysophospholipase I) (Palmitoyl-protein hydrolase),LYPLA1,17,16.5,15.9
M3VUP6,Lymphatic vessel endothelial hyaluronan receptor 1,LYVE1,29,20.1,20.7
A0A2I2UY37,"Mannose-6-phosphate receptor, cation dependent",M6PR,18.4,10.3,10.6
A0A337SQ63,Mucosal vascular addressin cell adhesion molecule 1,MADCAM1,24.7,19.2,19.6
A0A5F5Y426,"alpha-1,2-Mannosidase (EC 3.2.1.-)",MAN1A1,24.7,24.7,25.3
A0A5F5XC46,"alpha-1,2-Mannosidase (EC 3.2.1.-)",MAN1A2,10.5,18.7,10.8
A0A5F5Y2G5,Alpha-mannosidase (EC 3.2.1.-),MAN2A1,22.1,20.7,20.2
M3WBE5,Alpha-mannosidase (EC 3.2.1.-),MAN2A1,19.7,16.6,16
A0A5F5XUG7,Alpha-mannosidase (EC 3.2.1.-),MAN2A2,19,15.9,16.1
A0A2I2UJS0,Alpha-mannosidase (EC 3.2.1.-),MAN2B1,17.9,17.1,17.7
O46432,Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B),MAN2B1 MANB,25.5,25.8,27
A0A337RVS9,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase),MANBA,23.3,23.3,22.3
A0A337SHI7,MANSC domain containing 1,MANSC1,21.7,17.6,17.6
A0A337S396,Monoamine oxidase B,MAOB,16.5,18.2,17.9
A0A337S9V8,Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25),MAP3K12,17.9,18.5,19
M3WAB7,Mitogen-activated protein kinase (EC 2.7.11.24),MAPK7,21,18.3,15.8
M3XB86,RING-type E3 ubiquitin transferase (EC 2.3.2.27),MARCHF10,20.7,21.1,21
A0A2I2UHZ6,MBL associated serine protease 1,MASP1,21.3,22,22.4
A0A337S8F8,MBL associated serine protease 2,MASP2,26.5,20.7,20.6
A0A5F5Y096,MBL associated serine protease 2,MASP2,20.1,20.7,20.7
A0A2I2UI11,Mannose binding lectin 1,MBL1,19.9,21.3,20.7
A0A5F5XHB5,Melanoma cell adhesion molecule,MCAM,21.1,20.2,21
Q7YRU4,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Aromatic alpha-keto acid reductase) (KAR) (EC 1.1.1.96) (Cytosolic malate dehydrogenase)",MDH1,24.1,21.6,21.3
K0J107,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)",MDH2,17.1,10.3,10.7
A0A337S3Q9,Midkine,MDK,20.1,16.2,16.1
A0A2I2UC58,Multiple EGF like domains 9,MEGF9,23.9,19.8,19.7
M3W126,Melanotransferrin,MELTF,26,26.8,27.7
M3WB64,Metalloendopeptidase (EC 3.4.24.-),MEP1A,26,17.6,18.6
A0A5F5Y369,receptor protein-tyrosine kinase (EC 2.7.10.1),MERTK,16.6,17.1,17.2
M3XFR1,Meteorin-like protein,METRNL,21.7,19.7,21.5
A0A337SHC5,Microfibril associated protein 4,MFAP4,19.8,22.8,21.7
M3XGE7,Microfibril associated protein 4,MFAP4,20.8,21.6,20.6
A0A5F5XE10,Milk fat globule EGF and factor V/VIII domain containing,MFGE8,25.7,21.7,22.5
A0A2I2UXR9,Maltase-glucoamylase,MGAM,26.6,24.5,23.8
A0A341ZMF3,"alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase (EC 2.4.1.155)",MGAT5,24,22.6,22.6
A0A2I2V3J5,Matrix Gla protein (MGP),MGP,19.4,21.3,21
A0A2I2UBB6,SH3 domain-containing protein,MIA2,19.8,15.3,15.3
A0A337RWW9,MIA SH3 domain ER export factor 3,MIA3,23,18.8,18.3
A0A5F5XNZ1,Migration and invasion enhancer 1,MIEN1,24.1,23.1,22.7
M3WPV6,Migration and invasion enhancer 1,MIEN1,23.5,17.2,17.2
A0A5F5XHI0,Macrophage migration inhibitory factor (EC 5.3.2.1) (EC 5.3.3.12) (L-dopachrome isomerase) (L-dopachrome tautomerase) (Phenylpyruvate tautomerase),MIF,21,15.6,16.6
A0A337S3R5,Multiple inositol-polyphosphate phosphatase 1,MINPP1,20.8,18.7,18.8
M3WV39,"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (EC 3.1.3.80) (2,3-bisphosphoglycerate 3-phosphatase)",MINPP1,19.5,19.7,19.9
A0A5F5XFE9,Microtubule interacting and trafficking domain containing 1,MITD1,16,11,10.5
A0A337SXF4,Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (Skin fibroblast elastase),MME,25.4,22,22.2
A0A5F5XYE2,Matrix metallopeptidase 11,MMP11,14.8,17.2,17.6
A0A337S0K7,72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Matrix metalloproteinase-2),MMP2,15.4,18.2,18.3
P55032,Matrilysin (EC 3.4.24.23) (Matrin) (Matrix metalloproteinase-7) (MMP-7) (Pump-1 protease) (Uterine metalloproteinase),MMP7,16.6,15.7,17.4
A0A5F5Y5F5,Matrix metalloproteinase-9 (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B),MMP9,23.2,18.5,15.1
A0A3S6CJJ2,Matrix metallopeptidase 9,MMP9,23.9,18.1,18
M3WI37,Multimerin 1,MMRN1,23.5,17.9,18.5
A0A5F5XUK2,Multimerin 2,MMRN2,12.8,12.1,12.3
A0A337SLC9,Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B),MOCS2,18.4,15.6,15.8
M3WCF8,Monooxygenase DBH like 1,MOXD1,21,15.5,15.6
A0A337S4A6,Megakaryocyte and platelet inhibitory receptor G6b,MPIG6B,21.4,14.2,17.3
A0A337S0Y0,Sulfurtransferase,MPST,26,23.8,23
A0A2I2UHE7,Myelin protein zero like 1,MPZL1,20.5,14.4,13.8
M3WFQ7,Myelin protein zero like 2,MPZL2,27.2,20.7,21.3
A0A5F5XC23,Mannose receptor C-type 1,MRC1,16.1,14.4,13.5
A0A2I2V193,Mannose receptor C-type 1,MRC1,18.3,15.1,15.2
M3WE80,Mannose receptor C type 2,MRC2,20.1,17.7,17.1
A0A337SNX4,Moesin (Membrane-organizing extension spike protein),MSN,23.9,22.4,23.6
M3WJI8,Moesin (Membrane-organizing extension spike protein),MSN,20.1,19.8,20.3
A0A2I2UAP2,Macrophage stimulating 1,MST1,22.5,21.9,22.4
M3WPT7,Growth/differentiation factor 8 (GDF-8) (Myostatin),MSTN,16.6,18.9,19.2
A0A2I2UW30,methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9),MTHFD2L,23.3,16.5,17.2
A0A337SL83,Multivesicular body subunit 12A (ESCRT-I complex subunit MVB12A) (Protein FAM125A),MVB12A,20.5,19.3,19.4
A0A337S8H7,Matrix remodeling-associated protein 8,MXRA8,29.5,20.3,20.4
A0A337SH59,Matrix remodeling-associated protein 8,MXRA8,25.5,18.5,19.3
A0A2I2U1C5,"Myosin-9 (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain IIa)",MYH9,22.8,20.9,21.3
A0A2I2UHR0,Myosin light chain 6,MYL6,18.4,18.5,18.5
A0A2I2U033,"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)",MYL9,17.7,13.6,14
A0A337S3Q0,Myosin light chain kinase,MYLK,24.6,20,20.2
A0A5F5XC70,Myosin light chain kinase 2,MYLK2,16.6,17.2,18.3
Q594P2,"Myocilin [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment)]",MYOC,24.8,20,20
A0A2I2V455,N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.23) (EC 3.5.1.60) (Acylsphingosine deacylase NAAA),NAAA,30.9,20.6,21
A0A5F5XU62,Alpha-galactosidase (EC 3.2.1.-),NAGA,21.8,15.8,16.3
M3WFH8,N-acetyl-alpha-glucosaminidase,NAGLU,25.6,21.1,21.7
A0A337S914,Nucleosome assembly protein 1 like 4,NAP1L4,18.1,19.4,19.5
A0A5F5XWA2,Napsin A aspartic peptidase,NAPSA,29.7,18.8,18.3
A0A2I2UVF9,"NBL1, DAN family BMP antagonist",NBL1,26.2,19.9,20.3
A0A2I2UJV2,Neural cell adhesion molecule 1,NCAM1,24.6,24.7,25.6
A0A337S4H2,Neural cell adhesion molecule 1,NCAM1,20.4,19.3,19.2
A0A2I2V0Y5,Neural cell adhesion molecule 2,NCAM2,25.9,21.3,21.4
A0A337S9P8,Nicastrin,NCSTN,22.4,23.5,24.9
M3VZX9,Protein NDRG1 (N-myc downstream-regulated gene 1 protein),NDRG1,20.6,18,16.4
A0A5F5Y4C0,N-myc downstream regulated 1,NDRG1,18.7,10.9,11
A0A337RZV6,Nectin cell adhesion molecule 1,NECTIN1,21.7,18.7,18.9
A0A5F5XXT2,Nectin cell adhesion molecule 2,NECTIN2,27.1,21,21.4
A0A2I2U0E6,Nectin cell adhesion molecule 3,NECTIN3,20.9,17.8,18.4
A0A5F5XLH0,Nectin cell adhesion molecule 4,NECTIN4,26.1,19.8,19.5
A0A2I2UX82,Neuronal growth regulator 1,NEGR1,24.5,19.3,18.6
A0A337S1S7,Protein kinase C-binding protein NELL2 (NEL-like protein 2),NELL2,24.9,23.9,23.7
A0A2I2UTR9,Neogenin 1,NEO1,22.4,20.6,20.1
M3X3Z7,Sialidase-1 (EC 3.2.1.18) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1),NEU1,21.8,19.2,18.3
A0A2I2UTY5,Nexilin F-actin binding protein,NEXN,20.7,18.2,18.5
A0A337SBE9,Nerve growth factor receptor,NGFR,24.4,20,21.6
A0A2I2UP60,Na(+)/H(+) exchange regulatory cofactor NHE-RF,NHERF1,25.4,23.1,23
A0A2I2U5Z9,NHL repeat containing 3,NHLRC3,25.1,20.3,20.9
A0A337SCS7,Nidogen 1,NID1,25.2,23,21.8
A0A337SMW2,Nidogen 2,NID2,23.7,19.7,19.9
A0A337S9P2,NIPA like domain containing 1,NIPAL1,19.2,12.7,14.6
A0A5F5XC25,Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2),NIT2,22,17.5,17.1
A0A2I2U4B5,Nucleoside diphosphate kinase (EC 2.7.4.6),NME2,19.5,16.2,16.3
M3X077,Neurogenic locus notch homolog protein 1,NOTCH1,22.3,20.5,15.9
A0A2I2U0T9,Notch receptor 2,NOTCH2,20.2,17,16.3
A0A2I2UCH5,NPC intracellular cholesterol transporter 1,NPC1,20.9,16.4,16.6
A0A2I2U310,NPC1 like intracellular cholesterol transporter 1,NPC1L1 DDX56,21.3,17.1,17
M3X1L5,NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1),NPC2,27.3,22.6,22.2
M3X5Z4,Aminopeptidase (EC 3.4.11.-),NPEPPS,16.7,14,12.7
M3VXB4,"NPHS2 stomatin family member, podocin",NPHS2,15.2,10,14.4
A0A337S3Z8,Natriuretic peptide receptor 3,NPR3,17.8,14.7,15.3
A0A2I2UZY7,Neuroplastin,NPTN,21.5,16,16
A0A337SMV4,N-ribosyldihydronicotinamide:quinone reductase 2,NQO2,21.6,20.6,20
A0A2I2U1J3,Nuclear receptor subfamily 1 group H member 4,NR1H4,15.6,17.7,16.2
M3WN87,Nuclear receptor subfamily 1 group I member 3 (Constitutive androstane receptor),NR1I3,22.4,26.6,26.5
A0A2I2UU92,Neuropilin,NRP1,18.2,15.9,16.2
A0A337SMY8,Neuropilin 2,NRP2,17.7,16,15.5
A0A337S9F6,Neurexin 3,NRXN3,16.4,14.9,12
A0A5F5XIM5,NSFL1 cofactor,NSFL1C,19.6,21.1,21.7
A0A2I2UUB3,Neurotrimin,NTM,22.5,21.1,20.5
A0A2I2U1I4,Tyrosine-protein kinase receptor (EC 2.7.10.1),NTRK3,21.7,15.3,16.2
M3W064,Nucleobindin-1,NUCB1,25.9,22,22
A0A2I2UTH6,Nucleobindin 2,NUCB2,22.1,19.9,20
A0A2I2UU60,"Oxidized purine nucleoside triphosphate hydrolase (EC 3.6.1.56) (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase) (Nucleoside diphosphate-linked moiety X motif 1)",NUDT1,21.3,17.4,17.2
A0A2I2ULA8,Nuclear mitotic apparatus protein 1,NUMA1,19.9,16.4,17.8
M3X0F5,Nuclear transport factor 2 (NTF-2),NUTF2,25.4,20,20.5
A0A2I2ULL1,Neurexophilin,NXPH2,18.4,19,19.1
A0A2I2U0A2,Out at first protein homolog,OAF,22.8,22.1,21.9
M3WPJ4,2-oxoglutarate and iron dependent oxygenase domain containing 3,OGFOD3,16.3,15.6,16.8
M3VVG9,Mimecan (Osteoglycin),OGN,22.6,21.9,22.3
A0A337S4Z9,Olfactomedin 1,OLFM1,20.9,18.5,18.2
A0A337RWR2,Olfactomedin like 3,OLFML3,20.4,16.9,17.5
A0A2I2UMJ9,Opioid binding protein/cell adhesion molecule like,OPCML,22.5,19.3,19.7
A0A2I2UD00,Oxysterol-binding protein,OSBPL2 ADRM1,17.9,13,13.8
A0A5F5Y561,Otoraplin,OTOR,22.5,19.3,19.2
A0A337SC03,P2X purinoceptor,P2RX4,19.5,19.3,19
M3XCN6,Protein disulfide-isomerase (EC 5.3.4.1),P4HB,19.5,18.8,19.1
A0A337S9L8,Protein kinase C and casein kinase substrate in neurons 2,PACSIN2,21.1,18.9,19.3
M3WHA5,Protein kinase C and casein kinase substrate in neurons 3,PACSIN3,20.6,20.4,20.3
B0LSW3,Platelet-activating factor acetylhydrolase IB subunit beta (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha),PAFAH1B1 LIS1,21.3,19.1,19.4
M3WEF4,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),PALS1,16.4,18.5,19.2
A0A337S9K0,Peptidylglycine alpha-amidating monooxygenase,PAM,22.6,20.9,21
A0A2I2UHQ6,"Papilin, proteoglycan like sulfated glycoprotein",PAPLN,24.6,20.3,20.2
A0A5F5XQL5,"Papilin, proteoglycan like sulfated glycoprotein",PAPLN,20.5,17,16.9
M3WYR7,protein deglycase (EC 3.5.1.124) (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1) (Protein/nucleic acid deglycase DJ-1),PARK7,19.4,15.6,15.8
A0A337STF2,Parkinsonism associated deglycase,PARK7,22.2,18,18.1
A0A5F5XDU4,Phenazine biosynthesis like protein domain containing,PBLD,22.9,20.3,20.1
A0A5F5XDD6,Pterin-4-alpha-carbinolamine dehydratase (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase),PCBD1,21.4,18.4,18.8
A0A2I2U3P8,Poly(rC) binding protein 2,PCBP2,18.4,14.2,14.5
M3WBC6,Protocadherin 1,PCDH1,21.9,17.7,18.1
A0A2I2UWU3,Protocadherin 17,PCDH17,28.3,26.2,26.1
A0A337SKM2,Protocadherin 7,PCDH7,17.4,15.9,15.1
A0A5F5XH49,"Protocadherin alpha subfamily C, 2",PCDHAC2,19,16.1,16.3
A0A5F5XE18,"Protocadherin gamma subfamily A, 4",PCDHGA4,22.5,19.4,19.2
A0A5F5XK05,Procollagen C-endopeptidase enhancer,PCOLCE,26.6,24.3,24.2
M3W6K9,Procollagen C-endopeptidase enhancer,PCOLCE,21.3,18.4,17.9
A0A5F5Y2C4,Procollagen C-endopeptidase enhancer 2,PCOLCE2,20.7,16.1,17.2
A0A337SNW6,Proprotein convertase subtilisin/kexin type 5,PCSK5,13.7,21.7,22
M3WSQ5,Prenylcysteine oxidase 1 (EC 1.8.3.5),PCYOX1,14.5,15.9,16.7
A0A2I2UD44,Programmed cell death 6,PDCD6,25.2,26.3,26
A0A5F5Y1P9,Programmed cell death 6 interacting protein,PDCD6IP,25.3,25.3,24.5
M3XG34,Programmed cell death 6 interacting protein,PDCD6IP,20.6,16.4,17
M3VVR5,Phosphodiesterase (EC 3.1.4.-),PDE3A,16.1,15.6,13.6
W5LV43,Platelet-derived growth factor subunit B (PDGF-2) (Platelet-derived growth factor B chain) (Platelet-derived growth factor beta polypeptide),PDGFB,23.8,15.7,15.8
A0A5F5XER7,Platelet-derived growth factor D,PDGFD,20.3,20.3,19
K7S0M4,Platelet derived growth factor receptor beta,PDGFR-b,20.2,18.8,19.2
M3WAV8,Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor),PDGFRA,19.5,16,16.7
M3W0P6,Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor),PDGFRB,22.1,15.4,15.9
M3WFY4,Platelet-derived growth factor receptor-like protein,PDGFRL,21.1,18.2,16.1
M3W668,Protein disulfide-isomerase (EC 5.3.4.1),PDIA3,21.1,19.4,19
M3W9X1,Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 72),PDIA4,18.8,16.2,16.2
A0A2I2UBZ5,PDZ domain containing 1,PDZK1,25.5,21.6,22.2
A0A5F5XK30,PDZK1-interacting protein 1,PDZK1IP1,22.3,17.3,17.2
M3WVN7,Platelet endothelial aggregation receptor 1,PEAR1,19.3,15.7,15.7
A0A2I2ULZ1,Phosphatidylethanolamine-binding protein 1 (HCNPpp),PEBP1,25,20.1,20.3
A0A337RYP8,Phosphatidylethanolamine binding protein 4,PEBP4,19.5,19.2,19.2
A0A2I2V340,Platelet and endothelial cell adhesion molecule 1,PECAM1,23.9,22.9,22.5
A0A5F5XCK4,Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1),PEF1,20.7,19.3,19.1
A0A2I2U2M1,Peptidase D,PEPD,21.9,21.4,21.7
M3WEL8,Profilin,PFN1,21.9,20.1,20.4
A0A337S381,Profilin,PFN2,20,13.2,13.5
A0A337S2Y5,Phosphoglycerate mutase (EC 5.4.2.11) (EC 5.4.2.4),PGAM1,19.6,18,17.6
A0A5F5XZL7,Pepsinogen B1,PGB1,22.4,15.5,15.4
M3X9S4,Pepsinogen B2,PGB2 OVGP1,19,12.2,11.9
A0A5F5XK20,Protein-glucosylgalactosylhydroxylysine glucosidase,PGGHG,19.8,18.1,18.6
M3WJN8,Protein-glucosylgalactosylhydroxylysine glucosidase,PGGHG,18.8,15.4,15.6
A0A2I2UJH0,Phosphoglycerate kinase (EC 2.7.2.3),PGK1,23.3,19,19.1
M3X166,Phosphoglycerate kinase (EC 2.7.2.3),PGK2,19.3,10.3,10
M3WZT2,Peptidoglycan recognition protein 1,PGLYRP1,14.4,17.6,18.8
M3WJ85,Peptidoglycan recognition protein 2,PGLYRP2,21.6,24.6,24.5
M3X816,14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (Protein histidine phosphatase),PHPT1,24.5,19.8,19.9
A0A2I2V147,Phytanoyl-CoA dioxygenase domain-containing protein 1,PHYHD1,19.1,19.3,19.6
A0A2I2UJP1,Peptidase inhibitor 15,PI15,24.1,18.6,18.5
M3WXF2,Peptidase inhibitor 16,PI16,21.7,18.8,18.3
A0A5F5XJM9,Peptidase inhibitor 16,PI16,24.9,21.1,21.4
A0A337SF63,Piezo type mechanosensitive ion channel component 2,PIEZO2,19.3,16.2,19.2
M3W5Z6,Polymeric immunoglobulin receptor,PIGR,30.4,25.4,25.7
A0A337S1V9,Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL),PIK3IP1,28.3,17,16.9
M3VWF4,Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL),PIK3IP1,26.2,13.7,13.7
M3X4Z4,Phospholipase A2 inhibitor and LY6/PLAUR domain containing,PINLYP,19.8,22.5,24.4
A0A337SBR4,Prolactin-induced protein,PIP,26.6,19.8,20.3
A0A337SAH5,PITH domain containing 1,PITHD1,22.7,17.9,19
A0A5F5XE98,"Protein kinase domain containing, cytoplasmic",PKDCC,19.8,17,16.4
A0A337RYU6,PKHD1 ciliary IPT domain containing fibrocystin/polyductin,PKHD1,19.9,18.8,18.6
M3X3Z1,PKHD1 like 1,PKHD1L1,21.4,21.5,19.9
A0A337RYI0,Pyruvate kinase (EC 2.7.1.40),PKM,18.8,18.2,19.2
P11979,Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2),PKM PKM2,22.9,20.8,20.7
M3X3D3,Phospholipase A2 group XV (EC 3.1.1.32) (EC 3.1.1.4) (EC 3.1.1.5) (1-O-acylceramide synthase) (LCAT-like lysophospholipase) (Lysophospholipase 3) (Lysosomal phospholipase A and acyltransferase) (Lysosomal phospholipase A2),PLA2G15,24.4,23.1,23.5
A0A5F5XCP1,1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47),PLA2G7,20.2,22.4,22.4
A0A337S474,Urokinase-type plasminogen activator (EC 3.4.21.73),PLAU,30.5,21.8,21.3
A0A337S388,Urokinase plasminogen activator surface receptor,PLAUR,22.4,17.6,18.3
A0A2I2UDS4,Phospholipase B-like (EC 3.1.1.-),PLBD2,26.7,23.8,23.3
A0A5F5XE59,5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3),PLD3,23.5,20.3,20.1
M3X3T9,Plasminogen (EC 3.4.21.7),PLG,27.4,28,28
M3VU17,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1)",PLOD1,17.9,17.4,17.1
A0A2I2UIC2,procollagen-lysine 5-dioxygenase (EC 1.14.11.4),PLOD2,21.8,20.3,20.8
A0A2I2U3Y6,Phospholipid transfer protein,PLTP,20.2,22.6,21.3
M3WCF9,Plexin domain containing 1,PLXDC1,20.5,18.2,18.8
A0A337SP16,Plexin domain containing 2,PLXDC2,21.9,20.5,20.4
A0A5F5Y1Y2,Plexin domain containing 2,PLXDC2,21,16.6,17.4
M3WG01,Plexin B2,PLXNB2,24.4,21.7,21.9
M3VU38,Plexin D1,PLXND1,18.8,18.8,18.4
M3WKB5,Xaa-Arg dipeptidase,PM20D2,23.3,18.3,18.3
M3W6S5,Purine nucleoside phosphorylase (EC 2.4.2.1) (Inosine-guanosine phosphorylase),PNP,14.2,12,12.3
A0A5F5XX38,POTRA domain-containing protein,PNPLA3,20.5,19.1,19.6
A0A5F5XE19,Podocalyxin (Podocalyxin-like protein 1),PODXL,25.4,21.5,21.6
A0A2I2UU74,Paraoxonase (EC 3.1.1.2),PON1,24.4,29.8,29.9
M3WTQ9,Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase),PPA1,21.4,22.4,22.5
A0A5F5XSY1,C-X-C motif chemokine,PPBP,22,24.3,27.2
A0A0A0MPZ9,Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8),PPIA,21.3,17.3,17.8
Q8HXS3,"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]",PPIA CYPA,23.5,21.8,22.1
A0A2I2UBH3,Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8),PPIB,22,20.3,19.9
A0A2I2V3I6,Rho-related GTP-binding protein RhoC,PPM1J,22,17.3,16.5
A0A2I2V4A6,Protein phosphatase 2 scaffold subunit Aalpha,PPP2R1A,16.5,16.9,16.5
A0A2I2V332,Protein phosphatase 4 regulatory subunit 4,PPP4R4,18.6,22.6,17.7
A0A337SU18,Palmitoyl-protein thioesterase 1,PPT1,19.3,14.5,14.9
A0A5F5XW18,Palmitoyl-protein thioesterase 2,PPT2,19.7,20.2,19.5
A0A2I2UW10,Protease associated domain containing 1,PRADC1,24,21,21.2
A0A2I2UQ65,thioredoxin-dependent peroxiredoxin (EC 1.11.1.24),PRDX1,23.8,20.3,20.9
A0A2I2UZE5,Peroxiredoxin-1 (EC 1.11.1.24),PRDX1,23.6,22,22.4
M3VUU2,Peroxiredoxin-2 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 2),PRDX2,18.9,19.7,21
A0A337SIG9,Peroxiredoxin-2 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 2),PRDX2,23.1,23,23.5
A0A5F5XXB7,"Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 3)",PRDX3,26.6,21.1,21
A0A5F5XS51,thioredoxin-dependent peroxiredoxin (EC 1.11.1.24),PRDX4,16.8,15.3,14
M3X1J5,Peroxiredoxin-5 (EC 1.11.1.24),PRDX5,21.7,18.5,18.5
A0A2I2UL25,Peroxiredoxin-6 (EC 1.11.1.27),PRDX6,24.2,21,21
A0A337S4R1,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,16.4,16.5,14.7
M3W340,Glucosidase 2 subunit beta,PRKCSH,20.8,18.5,19.4
O18754,Major prion protein (PrP) (CD antigen CD230),PRNP PRP,25.5,18.8,19
Q28412,Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV),PROC,21.4,23.7,23.7
A0A337SJB3,Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV),PROC,24.5,23.5,23.4
A0A5F5XMS8,Protein C receptor,PROCR,25.4,20.1,19.5
A0A2I2U9S5,Prominin 1,PROM1,22.9,22.4,20.7
M3WDQ9,Prominin 2,PROM2,24.3,24.8,24.8
A0A2I2USJ0,Vitamin K-dependent protein S,PROS1,25.5,27.2,26.6
A0A5F5XIU4,Vitamin K-dependent protein S,PROS1,21.5,22,20
A0A5F5XCK5,Proline rich transmembrane protein 4,PRRT4 RBM28,17.2,14.5,12.8
A0A5F5XUE5,trypsin (EC 3.4.21.4),PRSS2,23.7,19.2,19.2
A0A337RTP4,Serine protease 22,PRSS22,23.9,20.1,19.5
M3W107,Inactive serine protease 35,PRSS35,19.5,17,15.8
A0A5F5XEN1,Serine protease 53,PRSS53,20.9,18.9,19.3
A0A5F5XKF7,Serine protease 8,PRSS8,26.6,18.8,18.5
A0A5F5XI47,Prosaposin,PSAP,30.6,21.8,22.3
A0A2I2UM62,Prostate stem cell antigen,PSCA,24.7,18.6,18.9
M3WF05,Proteasome subunit alpha type,PSMA1,12.2,19,19.2
A0A5F5XCX3,Proteasome 20S subunit alpha 1,PSMA1,24,23.3,23.3
A0A2I2V2W1,Proteasome 20S subunit alpha 2,PSMA2,15.7,20,20.2
M3XAA2,Proteasome subunit alpha type,PSMA2,15.7,20.6,20.7
A0A337SD26,Proteasome subunit alpha type,PSMA3,18.5,20.9,19.7
A0A337S5C8,Proteasome subunit alpha type,PSMA4,20,20.4,20.6
A0A337SKX0,Proteasome subunit alpha type,PSMA4,18,19.3,19.5
A0A337SNJ1,Proteasome subunit alpha type,PSMA6,17.6,18.5,18.4
A0A2D0UF31,Proteasome subunit alpha type,PSMA6,20.3,19.2,19.4
A0A337SVW8,Proteasome 20S subunit alpha 6,PSMA6,13.1,16.7,16.9
A0A337S4A1,Proteasome subunit alpha type-7,PSMA7,19.6,22.5,22.8
M3W006,Proteasome subunit alpha type,PSMA7,17.4,20.3,20.4
A0A5F5XFT3,Proteasome subunit beta,PSMB1,23.1,22.3,22.2
A0A5F5XQW5,Proteasome 20S subunit beta 1,PSMB1,15.8,21,21.3
A0A2D0UJY9,Proteasome subunit beta,PSMB2,23.1,23,22.9
A0A5F5XNT6,Proteasome subunit beta,PSMB3,18.5,18.3,18.1
A0A2D0UF13,Proteasome subunit beta type-4,PSMB4,17.6,19.4,19.6
A0A337SNC1,Proteasome subunit beta,PSMB5,20.2,19.3,19.7
A0A2I2U3F3,Proteasome subunit beta,PSMB6,20.2,20.1,20.2
M3WKX9,Proteasome subunit beta,PSMB7,18.4,19.5,19.5
A0A2D0UUN5,Proteasome subunit beta,PSMB8,19.3,20.8,20.9
M3W4B6,Proteasome activator complex subunit 1 (Proteasome activator 28 subunit alpha),PSME1,16.3,13.9,15.9
A0A337SNE1,Phosphotriesterase-related protein (Parathion hydrolase-related protein),PTER,20.7,20.4,21.2
Q29487,Prostaglandin-H2 D-isomerase (EC 5.3.99.2) (Glutathione-independent PGD synthase) (Lipocalin-type prostaglandin-D synthase) (Prostaglandin-D2 synthase) (PGD2 synthase) (PGDS) (PGDS2),PTGDS,27.4,20.7,20.7
A0A2I2UXS9,Prostaglandin E2 receptor EP3 subtype (Prostanoid EP3 receptor),PTGER3,20.2,13.1,12
M3VXN4,Prostaglandin F2 receptor inhibitor,PTGFRN,23.4,20.6,21.2
A0A2I2V040,Prostaglandin reductase 1 (EC 1.3.1.48) (EC 1.3.1.74) (15-oxoprostaglandin 13-reductase) (Dithiolethione-inducible gene 1 protein) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase),PTGR1,15.1,16.1,16.6
A0A337SBR8,Protein tyrosine kinase 7 (inactive),PTK7,20.7,16.1,15.1
A0A337S1R3,Prothymosin alpha,PTMA,20.9,16.5,16.7
A0A337RYS5,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRD,25.1,22,22.2
A0A2I2UTT3,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),PTPRF,24.2,21.1,21.4
A0A337S5F4,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRG,25.2,21.2,21.3
A0A5F5XBP3,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRJ,19.6,20.9,21
A0A337RY95,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRK,22.9,21.6,20.6
A0A2I2URE9,Protein tyrosine phosphatase receptor type N,PTPRN,16.7,16,15.7
A0A337S6M3,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRO,18.7,21.1,21.1
A0A337SCB7,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRS,20.4,18.2,17.7
A0A337SQ52,Pentraxin 4,PTX4,22.3,18.9,19.2
A0A2I2UHS4,Pseudouridine 5'-phosphatase,PUDP,18,17.4,16.7
M3W8T7,tRNA pseudouridine(55) synthase (EC 5.4.99.25),PUS10,18.9,19.6,20.4
A0A2I2UQ14,Peroxidasin,PXDN,21.9,22.9,20.5
A0A5F5XPQ2,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2,PYROXD2,15.8,17.3,16.8
M3WST2,Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (Glutaminyl-tRNA cyclotransferase),QPCT,25.3,23,23.2
M3WH13,glutaminyl-peptide cyclotransferase (EC 2.3.2.5),QPCTL,20.7,20.9,20.9
A0A5F5Y4S8,Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]),QPRT,22.1,19.4,19.4
A0A2I2UE17,Sulfhydryl oxidase (EC 1.8.3.2),QSOX1,25.7,22.7,22.7
A0A5F5XH70,Ras-related protein Rab-10,RAB10,20.7,20.2,20.5
A0A5F5XXR7,Ras-related protein Rab-11A (EC 3.6.5.2),RAB11A,23.6,22.7,23.1
A0A337S2P7,RAB11 family interacting protein 5,RAB11FIP5,19.2,19.1,19.2
M3WTD7,Ras-related protein Rab-14,RAB14,19.1,15.5,14.9
A0A2I2UQJ5,small monomeric GTPase (EC 3.6.5.2),RAB1B,21.8,19.8,19.4
A0A2I2UAX8,small monomeric GTPase (EC 3.6.5.2),RAB27B,17.7,17.6,17.1
A0A2I2U095,"RAB35, member RAS onco family",RAB35,22.1,16.5,16.6
M3VYK6,Ras-related protein Rab-3,RAB3D,21,19.2,18.5
A0A2I2UAA6,Ras-related protein Rab-4,RAB4A,20.3,14.3,13.1
A0A5F5XRP9,Ras-related protein Rab-4,RAB4B,19.8,16.3,17.8
A0A337SHI5,small monomeric GTPase (EC 3.6.5.2),RAB5A,20.8,23.1,23.8
A0A337SSM4,small monomeric GTPase (EC 3.6.5.2),RAB5B,19.2,16.9,16.9
M3VXZ7,small monomeric GTPase (EC 3.6.5.2),RAB5C,20.1,20.3,20.4
A0A337SFP3,Ras-related protein Rab-7a,RAB7A,19.2,17.7,17.1
M3WRD9,Ras-related protein Rab-7a,RAB7A,18.9,11.8,12.9
A0A2I2UMT8,Ras-related protein Rab-8A (EC 3.6.5.2),RAB8A,22.1,16.5,16.6
A0A337SNI2,Rac family small GTPase 3,RAC3,22.9,20.9,21
M3WAZ7,Receptor activity modifying protein 2,RAMP2,19.3,13,12.8
M3WXV4,GTP-binding nuclear protein Ran,RAN,18.8,16.7,17.7
M3X4J3,small monomeric GTPase (EC 3.6.5.2),RAP1A,21.7,19.5,18.8
A0A2I2UBH5,"RAP2C, member of RAS onco family",RAP2C,16.3,16.3,17.8
A0A2I2UHV5,Retinoic acid receptor responder protein 2 (Chemerin),RARRES2,18.1,19.5,19.4
A0A2I2UGF8,Retinol binding protein 1,RBP1,20.3,18.9,20.3
M5AXY1,Retinol binding protein 4 (Feline conceptus protein 1) (fCP1) (Plasma retinol-binding protein) (PRBP) (RBP),RBP4,24.9,26.8,26.7
A0A337S713,RCAN family member 3,RCAN3,23.8,13.9,13.6
M3VTY8,Reticulocalbin 3,RCN3,21,18,18.1
A0A2I2U2A3,Radixin,RDX,25.5,21.9,22.2
A0A2I2UJB3,Radixin,RDX,19.1,17.3,16.7
A0A5F5XK46,Reversion inducing cysteine rich protein with kazal motifs,RECK,21.5,23.2,23.4
A0A1E1FFM2,Dickkopf 3 homolog,REIC Dkk-3,21.1,20.2,19.7
M3VZA9,RELT TNF receptor,RELT,20.3,13.6,13.2
M3WNP8,N-acylglucosamine 2-epimerase (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein),RENBP,18.7,17.6,17.2
A0A337S746,Resistin,RETN,23.7,14.6,15.3
A0A337SCF8,Resistin,RETN,23.9,19,18
A0A5F5XYD7,"Beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)",RFNG,16.1,14.1,13.7
A0A337SGN2,Repulsive guidance molecule BMP co-receptor a,RGMA,22.8,16.3,15.4
A0A2I2V4L0,Regucalcin (EC 3.1.1.17) (Gluconolactonase) (Senescence marker protein 30),RGN,18.6,13,15
A0A337SD93,Inactive rhomboid protein (iRhom) (Rhomboid family member) (Rhomboid veinlet-like protein),RHBDF2,16.3,12.5,11.2
M3WHT7,Ammonium transporter Rh type C (Rhesus blood group family type C glycoprotein),RHCG,20,13.2,13.8
A0A5F5XH32,Ammonium transporter Rh type C (Rhesus blood group family type C glycoprotein),RHCG,21.4,20,19.4
M3WU80,Transforming protein RhoA,RHOA,19.6,17.9,17.9
A0A2I2UTY4,Ras homolog family member Q,RHOQ,21.3,17,18
A0A2I2UD52,2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (Translation inhibitor L-PSP ribonuclease),RIDA,23.1,19.1,19.4
A0A5F5Y3Z8,"Ribonuclease A family member 1, pancreatic",RNASE1,27,16.9,18
A0A337SES4,Ribonuclease 4,RNASE4,19.5,22,21.6
M3WX61,Ribonuclease A family member k6,RNASE6,24.2,18.7,17.9
A0A337S1U9,Ribonuclease T2,RNASET2,23.6,21.2,20.8
A0A5F5XMF6,RING-type E3 ubiquitin transferase (EC 2.3.2.27),RNF13,19.9,15.7,15.7
A0A337STQ6,Ring finger protein 149,RNF149,18.1,17.5,17.9
A0A2I2UIU2,RING-type E3 ubiquitin transferase (EC 2.3.2.27),RNF167,20.4,19.9,19.7
M3W6G1,Roundabout guidance receptor 4,ROBO4,23.1,18.7,18.6
A0A2I2USV9,Receptor tyrosine kinase like orphan receptor 1,ROR1,23.4,17.8,18.2
A0A2I2UXP2,Receptor tyrosine kinase like orphan receptor 2,ROR2,23.3,19.9,20
M3X277,RAS related,RRAS,21.5,19.7,18.8
M3WBP8,RAS related 2,RRAS2,22.7,20.1,19.9
M3WH96,"RTF1 homolog, Paf1/RNA polymerase II complex component",RTF1,18.2,13.5,12.4
A0A2I2U7X2,Reticulon 4 receptor,RTN4R,22.8,21.1,20.4
A0A2I2U066,Reticulon 4 receptor like 1,RTN4RL1,14.9,12.3,12.8
A0A337S5J7,Reticulon 4 receptor like 2,RTN4RL2,24.8,21.8,21.6
M3VZI2,Receptor like tyrosine kinase,RYK,16.8,13.1,11.3
M3WK02,S100 calcium binding protein A12,S100A12,15.4,14.5,13.1
A0A2I2URR0,Protein S100 (S100 calcium-binding protein),S100A6,20.4,17,16.1
M3VZX1,Protein S100 (S100 calcium-binding protein),S100A9,20.1,16.7,16.7
M3W6R4,Sphingosine 1-phosphate receptor 1 (Sphingosine 1-phosphate receptor Edg-1),S1PR1,17.9,19.1,18.5
Q1T771,Serum amyloid A protein,SAA,17,18,18
P19707,Serum amyloid A protein (SAA) [Cleaved into: Amyloid protein A (Amyloid fibril protein AA)],SAA1,20.6,20.2,20.1
A0A337SKP2,Serum amyloid A protein,SAA1 LOC105260977,15.9,16.5,17
A0A5F5XKD6,Suprabasin,SBSN,24.1,18.5,16.8
A0A337RY68,Scavenger receptor class B member 2,SCARB2,19.1,16.8,16.9
M3WQ85,Carboxypeptidase (EC 3.4.16.-),SCPEP1,22.3,19.1,19.4
A0A5F5XHE0,Secernin-2,SCRN2,22.7,27.1,26.7
M3WBA3,Secernin-2,SCRN2,18,21.7,21.2
A0A2I2UX36,"Signal peptide, CUB domain and EGF like domain containing 1",SCUBE1,21.9,22.1,16.2
A0A337SWS1,"Signal peptide, CUB domain and EGF like domain containing 2",SCUBE2,24.1,20.7,19.5
A0A5F5XNW4,Syndecan 1,SDC1,20.2,15.4,16.4
A0A337S649,Syndecan,SDC2,22.5,14.4,14.4
M3X6M9,Syndecan 4,SDC4,26.9,19.5,20
A0A337S0T3,Syndecan binding protein,SDCBP,24.4,25.9,27.1
A0A5F5XYV1,Syndecan binding protein,SDCBP,19.7,10.5,10.6
M3W808,45 kDa calcium-binding protein (Stromal cell-derived factor 4),SDF4,23.8,20.2,20.5
A0A2I2UXY4,Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1),SELENBP1,23.5,21.5,21.9
M3VXE7,Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1),SELENBP1,21.9,19.9,19.9
A0A337S3N8,Selenoprotein F,SELENOF,19.8,20.3,21
A0A2I2U2J6,L-selectin,SELL,21.2,21.3,21.1
M3XD95,Semaphorin 4B,SEMA4B,21.1,18.9,18.5
M3W1S6,Semaphorin 4D,SEMA4D,17.5,13.5,13.6
A0A337SKV9,Semaphorin 4D,SEMA4D,21.5,19.4,19.6
A0A337S4F4,Semaphorin 5A,SEMA5A,18,15.9,14.5
A0A337RVW7,Semaphorin 5A,SEMA5A,19.4,17.9,18.9
A0A337S8G3,Septin,SEPTIN2,19.3,20.3,20.3
A0A5F5XW04,Serpin family A member 1,SERPINA1,28.5,30.1,30.2
M3WCX1,Serpin family A member 1,SERPINA1,28.4,29.9,30
M3WCX2,Serpin family A member 11,SERPINA11,15.2,14.5,14.3
M3WCX6,Serpin family A member 3,SERPINA3,22,23.5,23.6
M3WCX4,Serpin family A member 4,SERPINA4,21.8,24.6,24.4
A0A5F5Y5G3,Serpin family A member 5,SERPINA5,19.6,18.7,19
M3WCX0,Corticosteroid-binding globulin (Serpin A6) (Transcortin),SERPINA6,26.7,24.6,24.5
M3W9H4,Serpin B10,SERPINB10,20.9,19.4,20.6
A0A2I2UQ88,Serpin family B member 11,SERPINB11,16.1,15.5,10.2
A0A2I2UMR7,Serpin family B member 12,SERPINB12,24.3,20.7,22
M3WLL8,Antithrombin-III (Serpin C1),SERPINC1,28.2,31.3,31.3
M3W543,Serpin family D member 1,SERPIND1,24.5,28.2,28.3
M3W4Q4,Plasminogen activator inhibitor 1 (Endothelial plasminogen activator inhibitor) (Serpin E1),SERPINE1,14,16,16.5
M3W5N1,Serpin family F member 1,SERPINF1,25.2,28.7,28.8
M3W5N0,Serpin family F member 2,SERPINF2,23.3,25.2,25.2
A0A2I2U9A5,Serpin family F member 2,SERPINF2,26.1,28.5,28.4
A0A5F5XDM5,Serpin family G member 1,SERPING1,24.5,28.3,28.9
A0A5F5Y090,Serpin family G member 1,SERPING1,20.6,24.8,25.3
A0A5F5XLC7,Serpin family I member 1,SERPINI1,26.3,23.4,24
A0A5F5Y312,Stratifin,SFN,22.3,18.9,19.1
A0A2I2UR94,Secreted frizzled-related protein 1,SFRP1,18.6,13.5,14
M3X0E0,Secreted frizzled related protein 4,SFRP4,22.4,14.4,14.8
M3WNK3,Pulmonary surfactant-associated protein B (Pulmonary surfactant-associated proteolipid SPL(Phe)),SFTPB,20.2,13.5,13.2
A0A337SBP5,Sarcoglycan alpha,SGCA,22,16.3,16.2
M3VVP5,N-sulfoglucosamine sulfohydrolase,SGSH,24.3,22.3,22.2
A0A337RXI4,SH2B adaptor protein 1,SH2B1,20.6,16.3,18.5
M3WHM8,SH3 domain-binding glutamic acid-rich-like protein 3,SH3BGRL3,28.9,18.5,18.4
A0A5F5XDP8,Sex hormone-binding globulin,SHBG,23.5,26.6,26.4
A0A337SFV1,Sex hormone-binding globulin,SHBG,21.7,24.6,24.7
A0A5F5Y6V8,Sex hormone-binding globulin,SHBG,16.4,21.4,21.2
A0A337S703,Shisa family member 2,SHISA2,22,13.8,15.1
A0A337SBU4,Shisa family member 3,SHISA3,19,12.3,13.5
M3VUS4,Shisa family member 4,SHISA4,18,10.8,10.5
A0A2I2UZT1,Protein shisa-5 (Scotin),SHISA5,27.8,19.7,18.6
A0A337S6F7,Shisa family member 6,SHISA6,20.3,12.6,10.9
A0A5F5Y5C4,Shisa family member 7,SHISA7,18,11,10.4
A0A2I2UL92,Shroom family member 1,SHROOM1,23,23.6,24
M3W6U8,Sialic acid acetylesterase,SIAE,23.6,18,18.4
M3VYU4,Sialic acid acetylesterase,SIAE,22.6,20.5,21.2
A0A2I2UGY0,Solute carrier family 12 member 1,SLC12A1,24.3,24,23.6
A0A5F5XD74,Solute carrier family 12 member 3,SLC12A3,21.2,21.5,20.8
M3WNL1,Solute carrier family 12 member 4,SLC12A4,23.9,25.5,25.6
A0A2I2USM1,Monocarboxylate transporter 1 (Solute carrier family 16 member 1),SLC16A1,22.2,20.7,24.7
A0A337SUE7,Solute carrier family 22 member 1 (Organic cation transporter 1),SLC22A1,20.6,21.9,22.4
A0A337SCZ5,Solute carrier family 22 member 11,SLC22A11,19.2,14.9,13.9
A0A337RV27,Solute carrier family 22 member 12,SLC22A12,22.4,24.1,23.6
M3WGV2,Solute carrier family 22 member 13,SLC22A13,21.6,19.6,21
M3VX59,Solute carrier family 23 member 1,SLC23A1,21.5,22.1,21.5
A0A2I2UUV9,"Solute carrier family 25 member 3 (Phosphate carrier protein, mitochondrial) (Phosphate transport protein)",SLC25A3,22,18.6,18.2
A0A2I2URL1,"ADP/ATP translocase (ADP,ATP carrier protein)",SLC25A4,17.7,19.4,16.3
A0A5F5XZL1,Solute carrier family 28 member 1,SLC28A1,20.6,14.7,14.3
A0A2I2UA74,"Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine)",SLC2A5,19.4,19.2,17.6
M3VWU4,Sodium-dependent phosphate transport protein 2A (Na(+)-dependent phosphate cotransporter 2A) (Sodium/phosphate cotransporter 2A) (Solute carrier family 34 member 1),SLC34A1,19.9,20.3,20.4
M3VV37,Solute carrier family 3 member 1,SLC3A1,24.6,26.4,26.4
M3WLC0,Solute carrier family 3 member 2,SLC3A2,22.8,18,18.3
A0A2I2U4M0,Choline transporter-like protein,SLC44A2,19.9,23.6,24.4
A0A2I2UF62,Anion exchange protein,SLC4A4,16.6,13.4,11.2
A0A337SG91,Anion exchange protein,SLC4A4,21.2,19,19.8
A0A5F5XQN8,Sodium/glucose cotransporter 1 (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1),SLC5A1,21.3,17.5,18.4
A0A337SAB7,Sodium/mannose cotransporter SLC5A10 (Sodium/glucose cotransporter 5) (Solute carrier family 5 member 10),SLC5A10,18.6,15,15.1
M3WJJ1,Solute carrier family 5 member 12,SLC5A12,19.5,19.9,19.8
A0A5F5XDQ5,Solute carrier family 5 member 2,SLC5A2,21.1,19,18.7
M3WYV4,Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8),SLC5A8,20.1,20.4,21.5
A0A5F5XEN6,Solute carrier family 5 member 9,SLC5A9,18.2,18.1,17.7
A0A2I2UPJ1,Transporter,SLC6A1,19.3,14.9,14.2
A0A5F5XC30,Transporter,SLC6A18,19.6,18,18.1
M3WBM7,Transporter,SLC6A19,22.2,17.7,17.4
M3W1G1,Transporter,SLC6A8,20.5,18.5,18.7
M3XF74,Solute carrier organic anion transporter family member,SLCO4C1,21.3,19.4,19.5
M3VYI8,SLIT and NTRK like family member 1,SLITRK1,17.3,18.7,18.8
A0A2I2U579,SLIT and NTRK like family member 6,SLITRK6,16.7,14.5,14.9
A0A2I2UV69,Secreted LY6/PLAUR domain containing 1,SLURP1,20.1,10.8,11.1
A0A2I2UAJ7,Structural maintenance of chromosomes protein,SMC4,20.8,11.3,10.3
A0A337S693,Small integral membrane protein 22,SMIM22,19.7,16,16.2
A0A5F5Y4Q7,SPARC related modular calcium binding 1,SMOC1,19.7,19.2,19.6
M3X374,Sphingomyelin phosphodiesterase (EC 3.1.4.12),SMPD1,22.6,22.2,22.2
A0A5F5XFM9,Sphingomyelin phosphodiesterase acid like 3A,SMPDL3A,20.8,22.1,21.9
A0A2I2U480,Alpha-synuclein,SNCA,17.9,17.9,19.4
M3W8Q2,Gamma-synuclein,SNCG,21.9,21.3,21.3
M3X4X1,Sorting nexin,SNX18,15.4,11.2,10.6
A0A2I2UPH5,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),SOD1,25.7,22.2,22.4
A0A2I2U3N0,Superoxide dismutase (EC 1.15.1.1),SOD2,19.5,15.8,16
A0A337SS20,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),SOD3,23.8,21.1,21.8
A0A2I2V1M2,Sorbitol dehydrogenase (SDH) (XDH) (EC 1.1.1.14) (EC 1.1.1.9) (L-iditol 2-dehydrogenase) (Polyol dehydrogenase) (Xylitol dehydrogenase),SORD,21.8,21.1,20.4
A0A5F5XL46,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (Sorting protein-related receptor containing LDLR class A repeats),SORL1,21.8,21.4,21.3
M3WIG3,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (Sorting protein-related receptor containing LDLR class A repeats),SORL1,17.5,16.5,15.9
A0A5F5XK14,Sortilin 1,SORT1,22.8,22.9,21.5
M3WM95,Sortilin 1,SORT1,19.3,10.2,10.5
A0A5F5XKY6,SPARC (Osteonectin) (Secreted protein acidic and rich in cysteine),SPARC,19.3,15.3,16
A0A5F5XR50,SPARC like 1,SPARCL1,18.6,17,17.1
A0A2I2U991,Cytospin-A,SPECC1L,18.7,22.5,22.6
A0A2I2U9I8,Serine protease inhibitor Kazal-type 1 (Pancreatic secretory trypsin inhibitor),SPINK1,23.4,19.7,19.4
A0A2I2UZ18,Kazal-like domain-containing protein,SPINK2,19,14.7,14.1
M3WLW6,Serine peptidase inhibitor Kazal type 5,SPINK5,22.9,21,19.6
M3X7Y2,"Serine peptidase inhibitor, Kunitz type 2",SPINT2,20.3,16,15.4
A0A5F5XHK0,"Serine peptidase inhibitor, Kunitz type 2",SPINT2,18.7,13.5,15.7
M3WYD3,Theg spermatid protein like,SPMAP2L THEGL,21.3,18.4,18.7
M3WMU1,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1",SPOCK1,20.4,20.6,20.6
M3WI49,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2",SPOCK2,18.8,14.6,15.4
A0A337RYL8,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3",SPOCK3,18.5,16.4,15.8
A0A2I2UM84,Spondin 2,SPON2,16.7,15.5,15.4
A0A2I2UVQ2,Secreted phosphoprotein 1,SPP1,26.2,19.8,20
A0A5F5XTV6,Secreted phosphoprotein 24 (Secreted phosphoprotein 2),SPP2,23.8,22,22
A0A2I2UR05,Sepiapterin reductase (EC 1.1.1.153),SPR,20.1,19,19.4
A0A5F5XIW6,SREBP regulating gene protein,SPRING1,19,14.9,15.7
M3VVT0,SREBP regulating gene protein,SPRING1,16.7,12.5,14
A0A2I2U6D2,"Spectrin alpha, non-erythrocytic 1",SPTAN1,16.7,18.9,17.1
A0A337S5T6,Sarcalumenin,SRL,20.4,16.6,16.2
A0A5F5XQY8,Scavenger receptor cysteine rich family member with 5 domains,SSC5D,17.9,15.4,15.9
A0A2I2UHD5,"Type 2 lactosamine alpha-2,3-sialyltransferase (CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI) (ST3Gal VI) (Sialyltransferase 10)",ST3GAL6,21.9,18.9,19
M3WJN7,"beta-galactoside alpha-(2,6)-sialyltransferase (EC 2.4.3.1)",ST6GAL1,20,18.1,19.4
M3WN53,Stabilin 1,STAB1,19.4,18.1,18.6
A0A5F5Y3A1,Stanniocalcin-1 (STC-1),STC1,20.6,18.5,18.6
M3XCB8,Stomatin,STOM,20.1,19.1,18.3
A0A337SUF8,Stomatin,STOM,18.4,15.7,16.4
A0A2I2UP70,Syntaxin 3,STX3,20.7,20,20.4
M3VWX8,Syntaxin-binding protein 2 (Protein unc-18 homolog 2) (Protein unc-18 homolog B),STXBP2,26.1,24.9,22.8
A0A337RXK1,Arylsulfatase (EC 3.1.6.1) (EC 3.1.6.14) (N-acetylglucosamine-6-sulfatase),SULF2,24.3,21.9,22.2
M3WBD8,Sushi domain containing 2,SUSD2,21.4,18.3,16.9
A0A5F5XF46,Sushi domain containing 5,SUSD5,21.3,19,17.7
M3VZE1,Sushi domain containing 5,SUSD5,23.1,19.3,19
M3WVG6,Synapse associated protein 1,SYAP1,21.4,21.9,22.8
A0A5F5Y1D6,MARVEL domain-containing protein,SYPL1,21.9,21.3,21.8
A0A5F5XQX5,Transgelin,TAGLN2,20.7,20.2,20.4
A0A2I2U8C8,TAR DNA-binding protein 43,TARDBP,17.3,18.5,19.1
A0A2I2UTP2,TBC1 domain family member 31,TBC1D31,23.4,15.7,16
A0A337SNU3,TBC1 domain family member 32,TBC1D32,18.6,18.2,18.7
A0A5F5XD47,TBC1 domain family member 8B,TBC1D8B,19.8,16.6,16.6
A0A5F5XJ51,Transcobalamin-2 (Transcobalamin II),TCN2,22.6,22.8,22.6
M3X0W1,Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (Repressor/activator protein 1 homolog),TERF2IP,23.6,23.8,23.5
A0A5F5XNI1,Transferrin,TF,31.9,33.1,33.3
M3X260,Transferrin,TF,25.5,26.9,27
A0A5F5XXX0,Transferrin,TF,27,28.3,28.3
M3WBQ5,Transferrin,TF,28.6,29.1,29.2
B4X8D7,Trefoil factor 1 (Trefoil factor family peptide 1),TFF1,26.5,19.3,18
B4X8D8,Trefoil factor 2,TFF2,26.2,19.7,19.5
M3WI50,Tissue factor pathway inhibitor,TFPI,19.1,12.3,12.1
A0A5F5XDK9,Tissue factor pathway inhibitor 2,TFPI2,25.8,18.5,18.5
Q9MYZ3,Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (CD antigen CD71),TFRC,20.2,20.7,21.2
M3WKJ1,Transforming growth factor-beta-induced protein ig-h3,TGFBI,23.7,23,23.5
A0A337SBT0,TGF-beta receptor type-1 (EC 2.7.11.30) (Transforming growth factor-beta receptor type I),TGFBR1,20.9,19.1,18.2
A0A5F5XGQ1,Serine/threonine-protein kinase receptor (EC 2.7.11.30),TGFBR2,22.1,19.9,21.1
A0A5F5XD94,Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (EC 3.5.1.44) (Isopeptidase TGM2) (Protein-glutamine deamidase TGM2) (Protein-glutamine dopaminyltransferase TGM2) (Protein-glutamine histaminyltransferase TGM2) (Protein-glutamine noradrenalinyltransferase TGM2) (Protein-glutamine serotonyltransferase TGM2) (Tissue transglutaminase) (Transglutaminase-2),TGM2,22.7,20.7,21.3
A0A2I2UM78,Transglutaminase 5,TGM5,23.8,24.1,24.5
M3WF45,Thrombospondin 1,THBS1,26,24.5,24.9
A0A2I2UG29,Thrombospondin 2,THBS2,14,10,10.2
M3W148,Thrombospondin 4,THBS4,18.7,18.9,18.9
A0A5F5XNC0,Thymocyte selection associated family member 2,THEMIS2,18.8,17.9,18.4
A0A2I2UGV7,Thy-1 membrane glycoprotein (Thy-1 antigen),THY1,26.4,20,20
A0A337S209,receptor protein-tyrosine kinase (EC 2.7.10.1),TIE1,21.8,20.7,21.4
A0A337SK12,T cell immunoreceptor with Ig and ITIM domains,TIGIT,20.2,15.6,14.8
A0A2I2UP29,T cell immunoglobulin and mucin domain containing 4,TIMD4,28.1,21.2,20.7
A0A2I2U4F9,Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1),TIMP1,22.3,21.4,23.5
M3W949,Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1),TIMP1,23,22,23.4
A0A337SHQ6,Metalloproteinase inhibitor 2 (Tissue inhibitor of metalloproteinases 2),TIMP2,22.4,22.3,23.3
A0A2I2UAQ8,Metalloproteinase inhibitor 3 (Tissue inhibitor of metalloproteinases 3),TIMP3,21.3,19.6,19.6
A0A337SA15,Tubulointerstitial nephritis antigen,TINAG,24.6,17.2,17.2
A0A337S5K9,Tubulointerstitial nephritis antigen like 1,TINAGL1,20.7,11.4,11.2
A0A337S2N1,Triokinase/FMN cyclase (EC 2.7.1.28) (EC 2.7.1.29) (EC 4.6.1.15) (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)),TKFC,19.8,21.5,21.5
M3X940,Triokinase/FMN cyclase (EC 2.7.1.28) (EC 2.7.1.29) (EC 4.6.1.15) (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)),TKFC,18.8,13.5,13.2
A0A5F5Y1L1,Transketolase (EC 2.2.1.1),TKT,21.3,19.6,18.9
A0A2I2V2A4,Talin 1,TLN1,20,17.2,17.1
M3XFJ6,Transmembrane 7 superfamily member 3,TM7SF3,22.9,21.6,21.5
M3WPL3,Transmembrane and coiled-coil domains 5B,TMCO5B,19.5,12.1,12.6
A0A2I2UKF8,Transmembrane p24 trafficking protein 7,TMED7,23.3,20.2,20.9
A0A2I2UFI9,Transmembrane p24 trafficking protein 9,TMED9,16.5,16.2,15.7
M3WBR7,Transmembrane protein 102,TMEM102,14.6,15.5,14.6
M3W5X2,Transmembrane protein 106B,TMEM106B,24,13.2,15.4
A0A337S0Q7,Transmembrane protein 123,TMEM123,18,12.5,11.8
A0A5F5XDF0,Transmembrane protein 132A,TMEM132A,22,21.6,21.4
M3WP30,Transmembrane protein 132A,TMEM132A,18.2,16.3,15.7
M3WSW8,Transmembrane protein 256,TMEM256,21.1,11.5,12.5
A0A5F5XZP8,Transmembrane protein 277,TMEM277 KLK1,31.7,19,19.6
A0A5F5XRV1,Transmembrane protein 59,TMEM59,20.7,18.7,17.7
A0A2I2U348,Transmembrane protein 9,TMEM9,18.6,11.1,10.4
M3W8X2,Transmembrane serine protease 2,TMPRSS2,20.7,17.6,17.2
M3WTN0,Transmembrane serine protease 6,TMPRSS6,16.3,17.1,17.1
A0A2I2UFV7,Tenascin C,TNC,26.4,23,23.2
A0A2I2UUG3,Tenascin C,TNC,22.7,19.9,20.6
A0A2I2UQD4,TNF receptor superfamily member 11a,TNFRSF11A,20.9,18,17.6
A0A5F5XSD6,TNF receptor superfamily member 14,TNFRSF14,20.7,19.9,19
A0A2I2V223,Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (Tumor necrosis factor receptor type I) (p55) (p60),TNFRSF1A,16.9,12.6,12.8
A0A337SE86,TNF receptor superfamily member 1B,TNFRSF1B,24.4,21.4,22
A0A5F5Y208,TNF receptor superfamily member 4,TNFRSF4,18.4,17.5,17.9
A0A337SN48,TNF superfamily member 12,TNFSF12,20.8,17.5,16.9
A0A337S3S3,TNF superfamily member 13b,TNFSF13B,19.7,19.1,19.8
A0A337SCZ0,Tenascin N,TNN,19.5,14.3,14.1
M3X9A1,Triosephosphate isomerase (EC 5.3.1.1),TPI1,22.7,20,20.2
A0A2I2URE8,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),TPM1,16.3,14.9,15.7
A0A2I2U057,Tropomyosin 3,TPM3,21.2,20.2,20.4
A0A2I2UY85,Tropomyosin 3,TPM3,18.2,18.7,19.7
A0A5F5XI45,Tropomyosin 3,TPM3,13.9,16.4,16
A0A337RXS4,Nucleoprotein TPR,TPR,23.6,22,21.6
A0A337RUS6,Triggering receptor expressed on myeloid cells like 1,TREML1,23.1,16.4,19
A0A2I2UQM8,RING-type E3 ubiquitin transferase (EC 2.3.2.27),TRIM36,21,18.6,21.3
A0A337SU32,Tumor susceptibility 101,TSG101,22.8,21.9,22.4
A0A337SC81,"Tsukushi, small leucine rich proteoglycan",TSKU,18.2,17.6,17.9
M3VUZ7,Tetraspanin,TSPAN1,23.4,20.1,18.6
A0A2I2UDW9,Tetraspanin,TSPAN3,20.5,20.2,21
A0A2I2UB49,Tetraspanin,TSPAN8,22.8,21.1,19.3
M3WPX9,Tetratricopeptide repeat protein 38,TTC38,18.1,17.9,18.2
A0A337SAI4,Titin,TTN,22.7,23.9,21.6
M3WEV9,Transthyretin,TTR,28.1,31.3,31.3
A0A337S1Z7,Protein tweety homolog,TTYH3,21.9,23.4,19.2
A0A2I2U1M4,Tubulin alpha-1A chain,TUBA1A,21.5,22.1,22.6
A0A2I2UVC7,Tubulin alpha chain,TUBA1A,20.2,18.1,18.1
A0A2I2UZ20,Tubulin alpha chain,TUBA4A,20.8,18.7,18.4
A0A2I2UXF6,Tubulin beta chain,TUBB2B,17.7,16.7,16
A0A2I2UBF3,Tubulin beta chain,TUBB4A,20.1,20,20.3
A0A5F5XDY3,Tubulin beta 4B class IVb,TUBB4B,20.4,14.6,14.2
A0A2I2UAT5,Tubulin beta chain,TUBB6,23,19.5,19.4
A0A5F5XBV5,Tubulin gamma complex associated protein 6,TUBGCP6,22.3,17.6,17.9
M3X4Y2,Twisted gastrulation BMP signaling modulator 1,TWSG1,22.4,18.7,18.8
A0A337RU81,Thioredoxin,TXN,23.1,19.8,20.7
A0A2I2V2Q8,protein disulfide-isomerase (EC 5.3.4.1),TXNDC5,17.6,16.2,17.2
A0A2I2V0W1,"Thioredoxin reductase 1, cytoplasmic (EC 1.11.1.2) (EC 1.8.1.9) (Peroxidase TXNRD1) (Thioredoxin reductase TR1)",TXNRD1,20.9,19.9,19.1
P63052,Ubiquitin-ribosomal protein eL40 fusion protein (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40) (CEP52)],UBA52 UBCEP2,26.8,22.1,22.1
A0A2I2UFV8,E2 ubiquitin-conjugating enzyme (EC 2.3.2.23),UBE2G2,23.7,16.4,16.3
A0A337S307,E2 ubiquitin-conjugating enzyme (EC 2.3.2.23),UBE2L3,16.2,13.5,14.9
M3X7A8,Ubiquitin like 7,UBL7,20.7,13.8,14.1
M3VWB5,UDP-glucose glycoprotein glucosyltransferase 1,UGGT1,21.1,21.1,21.1
M3W230,Uromodulin,UMOD,32.3,21.1,21.2
A0A337S3Y7,Uroplakin-1b (Uroplakin Ib),UPK1B,17.2,15.1,14.8
M3WUK1,Uroplakin 2,UPK2,19.1,12,10.5
A0A5F5XVJ0,Uroplakin 3A,UPK3A,17.2,16.5,14.5
A0A5F5XS01,Ubiquitin-related modifier 1,URM1,18.1,17.5,18
A0A2I2U2G1,USH1 protein network component harmonin,USH1C,13.8,13.8,12.9
A0A5F5Y2F0,VAMP associated protein B and C,VAPB,21.5,17.6,17.5
M3WEQ2,Vasorin,VASN,26.6,20,19.7
M3WIA9,Vesicle amine transport 1,VAT1,20.8,21.1,21.4
A0A337RXZ6,Vascular cell adhesion molecule 1,VCAM1,27.8,24.2,24
M3WED4,Vascular cell adhesion molecule 1,VCAM1,25.4,20.7,20.6
A0A2I2UH10,Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Large fibroblast proteoglycan) (PG-M),VCAN,17.1,15.6,14.9
M3VW05,Transitional endoplasmic reticulum ATPase (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein),VCP,19.6,18.8,18.2
A0A2I2UXU4,Voltage-dependent anion-selective channel protein 1,VDAC1,23.5,23.3,23.7
M3X2J1,Voltage-dependent anion-selective channel protein 2,VDAC2,23.5,19.6,20
A0A2I2V1K5,Voltage-dependent anion-selective channel protein 3,VDAC3,21,17.3,17.6
M3VYE6,Villin-1,VIL1,23.8,23,22.4
A0A2I2U8W9,Vimentin,VIM,24.1,21.4,21.7
A0A337SUD5,Vasoactive intestinal peptide receptor 1,VIPR1,19.1,14.3,14.7
A0A2I2UCX4,Very low density lipoprotein receptor,VLDLR,18,11.7,11.5
M3W8U6,Vitelline membrane outer layer 1 homolog,VMO1,26.7,21.9,21.7
A0A5F5XTH2,Vanin 1,VNN1,23.4,25,24.8
A0A2I2UUX6,Vanin 1,VNN1,24,25.5,25.6
A0A337S0D4,Vanin 1,VNN1,20.7,22.9,23
A0A5F5XLU4,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1),VNN1,21.8,18.8,17.9
A0A5F5XLV1,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1),VNN1,21.3,17.6,17.8
A0A337SIC4,Vacuolar protein sorting-associated protein 16 homolog,VPS16,19.4,18.3,17.2
A0A5F5XEZ3,Vacuolar protein sorting-associated protein 18 homolog,VPS18,22.2,17.2,17.4
A0A5F5XGU3,VPS18 core subunit of CORVET and HOPS complexes,VPS18,22.6,21.3,21.1
A0A2I2UFC7,Vacuolar protein-sorting-associated protein 25 (ESCRT-II complex subunit VPS25),VPS25,19,16.6,16.3
A0A5F5XWJ8,Vacuolar protein sorting-associated protein 28 homolog,VPS28,19.9,19.6,18.9
A0A337SJF6,VPS37D subunit of ESCRT-I,VPS37D,20.2,19,18.3
A0A2I2UNJ3,vesicle-fusing ATPase (EC 3.6.4.6),VPS4A,24,21.5,20.5
M3WXF7,vesicle-fusing ATPase (EC 3.6.4.6),VPS4B,21,19,19.4
A0A5F5XJU3,V-set and immunoglobulin domain containing 4,VSIG4,21.1,17.3,18
M3WEH0,V-set and transmembrane domain containing 2B,VSTM2B,20.5,15.4,16
M3XCE8,V-set and transmembrane domain containing 5,VSTM5,18.1,15.1,15.7
A0A337S1D0,Vesicle trafficking 1,VTA1,21.8,21,21.2
M3W9I5,Vitronectin,VTN,27.5,27.6,27.6
M3WSQ2,von Willebrand factor A domain-containing protein 1,VWA1,19,17.3,17.7
M3XCS6,von Willebrand factor C and EGF domains,VWCE,19.6,17.9,18.2
A0A061DD19,von Willebrand factor (vWF),VWF,22.7,22.6,22.9
A0A337S7R6,von Willebrand factor (vWF),VWF,15.8,15.7,13.5
M3W7M9,WDFY family member 4,WDFY4,15.5,14.2,14.2
A0A2I2UEP1,WD repeat domain 1,WDR1,21.7,21.7,21.8
A0A5F5XN85,WD repeat-containing protein 37,WDR37,19.9,20.2,19.6
A0A337SCH3,WAP four-disulfide core domain protein 2,WFDC2,27.9,14.7,16.2
M3W8X1,X-prolyl aminopeptidase 2,XPNPEP2,16.9,12.6,14.8
M3VVC0,Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I),XYLT1,20.1,14.7,14
M3VZR2,YEATS domain containing 2,YEATS2,22.4,24.1,23.8
A0A5F5XCJ6,Protein YIPF3 (YIP1 family member 3),YIPF3,28.1,16.4,17.4
M3WFK3,14-3-3 protein beta/alpha,YWHAB,20.6,19.8,21
A0A337SCS9,14-3-3 protein epsilon,YWHAE,23.4,20.2,20.5
M3VWG1,14-3-3 protein gamma,YWHAG,20.8,20.1,20.4
A0A5F5XZJ4,14-3-3 protein theta,YWHAQ,21.8,19.3,20.2
M3WVC7,14-3-3 protein zeta/delta,YWHAZ,22.5,19.7,19.3
A0A5K1VG18,14-3-3 protein zeta/delta,YWHAZ,20.2,15,14.2
A0A2I2UTC5,Zinc finger C4H2-type containing,ZC4H2,15.7,20.4,20.2
A0A5F5XBP5,Zymogen granule protein 16B,ZG16B,20.5,19.3,22.4
A0A337SLM1,Zinc finger with KRAB and SCAN domains 1,ZKSCAN1,27,26.5,26.4
M3WPT0,Zinc finger with KRAB and SCAN domains 1,ZKSCAN1,26.4,25.5,25.5
A0A2I2UXF5,Zinc finger with KRAB and SCAN domains 1,ZKSCAN1,24.5,23.3,23.3
A0A5F5XU81,Secreted and transmembrane 1,,28.5,21.4,22.7
A0A2I2U5G8,Fibronectin type-III domain-containing protein,,25.7,26.1,25.5
A0A5F5XGI8,Filaggrin,,22.4,16.6,16.9
A0A5F5Y249,Envelope polyprotein,,22.8,23.1,23.1
A0A291NGR0,IgA constant region,,25.8,21.5,21.8
A0A337S3R0,Sushi domain-containing protein,,27.4,26.2,26.2
A0A5F5XER5,Complement C3,,25.5,29.4,29.5
A0A5F5XL80,Anaphylatoxin-like domain-containing protein,,25.9,29.1,29.2
A0A291NH43,IgG lambda chain constant region,,15.5,17.9,16.7
A0A2I2V2Y7,Sushi domain-containing protein,,26.5,23.7,23.4
A0A2I2ULZ3,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),,25.3,18,19.7
M3W0R2,SRCR domain-containing protein,,22.3,15.6,15.1
A0A337SP31,Galectin,,20.6,18.3,18.7
T2HUL6,Restriction factor for feline retrovirus X,,18.1,20.1,19.8
A0A291NH71,Ig lambda variable,,28.2,25.3,26
A0A291NH36,IgG lambda chain constant region,,31.7,29.9,30.1
A0A291NH39,IgG lambda chain constant region,,20.8,20.5,19.5
A0A976N0B1,Endogenous retrovirus group V member 2 Env polyprotein-like,,24.6,19.3,19.7
M3X050,Ig-like domain-containing protein,,23,19.7,19.8
A0A291NGR2,IgA constant region,,26.7,21.2,22.2
A0A2I2V460,Trans-golgi network protein 2,,23.4,20.6,21.1
A0A337SE59,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (Keratin-19)",,22.1,19.2,18.8
A0A291NGW6,IgH variable region,,16.4,17.8,17.6
A0A291NGQ8,IgA constant region,,32,26.9,27.2
A0A291NH16,Ig kappa chain,,23,20.7,20.3
A0A291NHD0,IgG constant region,,30.3,31.2,31.4
A0A291NH41,Ig kappa chain,,19.4,16.4,17.1
M3X5X6,Sushi domain-containing protein,,25,22.5,22.4
A0A291NGT6,IgH variable region,,25.1,24.1,23.9
A0A2I2UCP1,WAP domain-containing protein,,24.1,14,14.6
A0A5F5Y223,Sushi domain-containing protein,,25.3,22.3,22
A0A2I2U526,Cytochrome c domain-containing protein,,21.2,18.3,18.7
A0A5F5XCZ4,Anaphylatoxin-like domain-containing protein,,24.4,26.7,26.6
A0A337SKT0,EF-hand domain-containing protein,,20,18.8,19
A0A2I2UN09,Ig-like domain-containing protein,,26.3,26.5,26.6
A0A5F5XS16,Sushi domain-containing protein,,21.8,17.1,16.1
A0A291NH33,IgG lambda chain constant region,,28.8,27.7,28.1
A0A5F5XWJ9,Ig-like domain-containing protein,,19.6,18.3,18
A0A291NH74,IgG lambda chain constant region,,28.1,26.3,26.1
M3X7R1,Ig-like domain-containing protein,,24.6,22.6,22.7
A0A337S7U4,Ig-like domain-containing protein,,27.7,28.1,28.6
T2HUV9,Restriction factor for feline retrovirus X,,24.2,21.7,21.6
A0A337SA19,Ig-like domain-containing protein,,19.3,20.2,19.3
A0A5F5XRP7,Ig-like domain-containing protein,,20.3,16.6,16.6
A0A291NH73,Ig lambda variable,,25.5,22.8,23
A0A5F5XZ87,Sushi domain-containing protein,,25,22,21.9
A0A2I2V5I2,Tripeptidyl-peptidase 1 (EC 3.4.14.9) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I),,25.4,21.7,22
A0A2I2UC18,Phosphoglycerate kinase (EC 2.7.2.3),,21.6,18,18.3
A0A2I2ULR9,14-3-3 protein epsilon,,23.5,20.8,20.8
A0A291NGT2,IgH variable region,,25.1,24.3,24.1
A0A2I2U5M6,Ig-like domain-containing protein,,16.4,17.7,18.2
A0A337SFW4,Ig-like domain-containing protein,,19.1,15.2,14.6
A0A291NH67,Ig lambda variable,,27.1,25.8,26.2
A0A337S672,Butyrophilin-like protein 1,,20.1,16.6,17.8
A0A5F5Y4V7,Ig-like domain-containing protein,,22.7,22.1,22.3
A0A5F5XUA3,"Mucin 2, oligomeric mucus/gel-forming",,19.3,20.8,21.3
A0A2I2UR81,Ig-like domain-containing protein,,23.2,19.6,20.1
A0A2I2U1K0,Ig-like domain-containing protein,,24.1,22.5,22.9
A0A291NHD9,IgG constant region,,29.6,30.5,30.7
A0A291NH87,Ig lambda variable,,26.6,24.6,24.8
A0A337SLR6,Folate receptor-like domain-containing protein,,24.3,15.8,16
M3XE23,Immunoglobulin V-set domain-containing protein,,20.3,16.8,17.2
A0A291NH84,Ig lambda variable,,19.2,17.2,17.6
A0A291NHB4,Ig lambda variable,,24.5,22.8,23
A0A337S804,Ig-like domain-containing protein,,24.5,22.1,22.5
A0A2I2U6W9,MHC class I-like antigen recognition-like domain-containing protein,,22.1,18.4,17.7
A0A5F5XCM1,Sushi domain-containing protein,,25.5,22.3,22
A0A337S723,Histone H4,,22.9,18.6,18.7
A0A291NH77,Ig lambda variable,,29.4,27,27.4
A0A5F5XIJ2,Complement C3,,18.3,20.1,19.8
A0A291NGY8,IgH variable region,,22.5,22.2,22.3
M3WIA6,Amine oxidase (EC 1.4.3.-),,21.4,21.7,21.6
A0A291NGZ4,Ig kappa chain,,29.7,27.3,27.5
A0A5F5XKA4,Anaphylatoxin-like domain-containing protein,,19.5,22.9,22.5
A0A291NHC4,Ig lambda variable,,22.4,21.3,20.9
A0A291NHA5,Ig lambda variable,,25.1,23.6,23.5
A0A291NHG6,IgG constant region,,22.8,25.2,26
A0A291NGZ9,Ig kappa chain,,24.8,23,23.7
A0A337RXE8,Heat shock protein family A (Hsp70) member 1B,,23.5,22.6,23.2
A0A5F5XT84,Ig-like domain-containing protein,,19,17.7,18.6
A0A291NHE9,IgG constant region,,23,24.7,24.6
A0A291NHA8,Ig lambda variable,,23.5,21.3,21.9
A0A291NGT3,IgH variable region,,24.5,24.3,24.2
A0A291NH42,Ig kappa chain,,20.4,18.8,19.7
A0A5F5XMZ4,SEA domain-containing protein,,23.2,18,18.5
A0A337S4X8,CUB domain-containing protein,,19.7,17.9,17.9
Q9J054,Infection accessory factor,,17.1,19.8,19.6
A0A2I2UI16,Ig-like domain-containing protein,,23.5,22.2,22.5
A0A5F5XM97,Anaphylatoxin-like domain-containing protein,,22.8,27,27.2
A0A5F5Y205,Ig-like domain-containing protein,,22.6,20.8,20.2
O97640,Fibrinogen A-alpha chain,,19,24.1,16.7
A0A291NH85,Ig lambda variable,,25.3,23.6,23
A0A5F5Y0U4,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (Keratin-8)",,21.4,16.3,15.3
A0A291NH29,Ig kappa chain,,19.1,16.9,17
A0A5F5XZG6,Ig-like domain-containing protein,,22.2,20.5,19.9
M1PYE6,Keratin 72,,19.6,17.6,18.1
A0A337SA21,Ig-like domain-containing protein,,17.1,13.2,13.3
A0A337S1X7,Ig-like domain-containing protein,,23.5,22.6,22.7
A0A291NH90,Ig lambda variable,,22.3,19.6,20
M3XG70,SMB domain-containing protein,,19.2,16.6,16.7
A0A291NGT9,IgH variable region,,21.2,20.2,20
A0A291NH93,Ig lambda variable,,24.9,22.8,23
A0A291NGW2,IgH variable region,,12.5,16.9,16.6
A9NJ73,lysozyme (EC 3.2.1.17),,19.9,18.8,19
A0A291NH95,Ig lambda variable,,22.1,22.2,21.4
A0A291NGX0,IgH variable region,,15,15.3,14.9
A0A291NH81,IgG lambda chain constant region,,25.6,23.1,23.5
A0A337SDR6,Protein S100-A11 (Calgizzarin) (S100 calcium-binding protein A11),,18.5,18.3,18.8
A0A291NHA0,Ig lambda variable,,24.6,22.1,21.9
A0A5F5XCM6,Ig-like domain-containing protein,,21.5,20.5,20.7
A0A291NH00,IgH variable region,,20,19.7,19.9
A0A291NHA9,Ig lambda variable,,22,20.2,20.3
A0A291NGZ6,Ig kappa chain,,27.8,25.5,25.6
A0A291NH96,Ig lambda variable,,20.5,20.9,18.9
A0A291NHC0,Ig lambda variable,,20.4,21.4,21.5
A0A291NHA2,Ig lambda variable,,27.5,25.2,25
A0A291NHB8,Ig lambda variable,,21.5,24.6,24.6
A0A5F5Y006,CUB domain-containing protein,,16,20.9,21.9
A0A291NGV1,IgH variable region,,21,20.3,20.3
A0A291NGW5,IgH variable region,,20,18.2,18.3
A0A291NH02,IgH variable region,,19.9,21,21.4
A0A291NGY1,IgH variable region,,24.8,24.3,24.1
A0A291NGU6,IgH variable region,,24.2,23.7,23.1
A0A291NGU9,IgH variable region,,19.9,19.5,19.4
A0A291NGW9,IgH variable region,,22.7,21.9,22
A0A291NGT1,IgH variable region,,29,28.6,28.9
A0A337SA37,Phospholipid scramblase,,21.3,17.7,18
A0A4P2TLQ8,BAFF-R protein,,22.3,11.4,10
A0A2I2UM04,Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8),,22.1,20.9,20.7
M3VU82,Peptidase S1 domain-containing protein,,19.2,19.5,21
M3XDV4,Ig-like domain-containing protein,,22.9,21.6,21.9
A0A291NHA1,Ig lambda variable,,24.4,22.1,22.4
A0A291NGU8,IgH variable region,,23.8,23.3,22.7
A0A291NH80,Ig lambda variable,,25.2,23.5,23.6
E3UTY8,S100A12,,23.2,19.6,19.5
A0A291NH69,IgG lambda chain constant region,,21.8,18.8,17.8
M3VU84,Peptidase S1 domain-containing protein,,20.8,22.7,21.9
A0A291NH98,Ig lambda variable,,22.9,21.6,22.1
A0A291NH32,Ig kappa chain,,21.4,19.7,19.8
A0A291NH99,Ig lambda variable,,22.9,22,22
A0A5F5XVX5,Ig-like domain-containing protein,,19.7,19.1,19.5
M3XG22,Ig-like domain-containing protein,,23.5,21.9,21.9
A0A291NH94,Ig lambda variable,,21.2,15.9,17.5
A0A291NH23,Ig kappa chain,,22.7,21,21.1
A0A2I2UNI7,UBC core domain-containing protein,,18.5,20.8,21.7
A0A291NGV6,IgH variable region,,20,20.6,20.3
A0A291NGX3,IgH variable region,,23.1,21.7,22
A0A5F5XYD4,IF rod domain-containing protein,,17.1,12.5,13
A0A291NGU3,IgH variable region,,27.1,26.5,26.1
A0A291NGW1,IgH variable region,,20,21.4,21.3
A0A291NGZ5,IgH variable region,,19.1,18.7,18.8
A0A291NHB2,Ig lambda variable,,21.5,18.8,19.9
A0A291NGU1,IgH variable region,,19.8,19.5,19.3
A0A5F5XTV7,Immunoglobulin V-set domain-containing protein,,19.4,15.8,18.1
A0A291NH88,Ig lambda variable,,26.4,23.8,23.9
A0A291NGX9,IgH variable region,,24.7,23.7,23.2
A0A5F5Y0A1,Ig-like domain-containing protein,,20.4,16,17.5
A0A291NH89,Ig lambda variable,,25.4,22.8,23.1
A0A291NH13,IgH variable region,,24.7,24.2,24.1
A0A291NGZ0,IgH variable region,,17.4,16.8,17
A0A291NGW0,IgH variable region,,17,18.2,18.3
A0A2I2UYJ1,Lactate/malate dehydrogenase C-terminal domain-containing protein,,18.2,12.8,12.2
A0A291NH06,Ig kappa chain,,21.6,19.6,19.6
A0A337S8X8,AHNAK nucleoprotein,,21.3,17.1,17.3
A0A291NGZ3,IgH variable region,,19.4,17.1,16.6
A0A291NH97,Ig lambda variable,,22.7,23.3,23.3
A0A291NGW7,IgH variable region,,24.2,23.4,23.5
A0A337SEH4,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (Keratin-8)",,19.9,15.6,15.5
A0A2I2UTJ7,Ig-like domain-containing protein,,18.8,17.9,16.7
A0A291NH59,IgG lambda chain constant region,,29.3,27,27.1
A0A5F5XIG1,Peptidase S1 domain-containing protein,,24.8,20.8,20.8
A0A291NGX1,IgH variable region,,25,25.5,25.5
A0A2I2UC78,Uncharacterized protein,,17.1,16.4,16.6
A0A291NGS0,IgA constant region,,19.2,19,19.7
A0A291NH78,Ig lambda variable,,23.3,22.5,22.9
A0A291NHB1,Ig lambda variable,,24.8,22.7,23.1
A0A337S574,Histone H2A/H2B/H3 domain-containing protein,,19,16.3,16.8
A0A291NGX5,IgH variable region,,23.6,23.1,23.4
A0A5F5XP86,Ig-like domain-containing protein,,20.3,19.7,20
A0A291NGT7,IgH variable region,,22.1,23.6,23.9
A0A337SPY8,NTR domain-containing protein,,22.3,15.3,14.8
A0A337SNS0,Olfactory receptor,,19.3,17.6,17.8
A0A337SNT6,CUB domain-containing protein,,18.8,16.4,16.5
A0A291NGZ7,IgH variable region,,19.9,19.4,19.7
A0A2I2U998,EF-hand domain-containing protein,,19.1,17.5,17.4
A0A291NHB5,Ig lambda variable,,18.8,18,16.8
A0A291NGY4,IgH variable region,,23.6,22.7,22.5
A0A291NH86,Ig lambda variable,,19.9,18.9,19.2
A0A291NHA6,Ig lambda variable,,18.6,19.3,19.2
A0A291NGT5,IgH variable region,,25.1,23.6,23.5
A0A2I2U5I7,Ig-like domain-containing protein,,21,17.1,17
A0A291NH27,Ig kappa chain,,19,18.2,18.5
B5LX42,Tubulin beta chain,,18.8,19.1,18.6
A0A5F5Y6H2,AHNAK nucleoprotein,,19,17.5,18.6
A0A291NH92,Ig lambda variable,,22,22.2,22.4
A0A5F5XI16,L1 transposable element RRM domain-containing protein,,21.6,14.7,16.5
A0A2I2URM2,Glutathione S-transferase (EC 2.5.1.18),,19.4,14.8,15.2
A0A5F5XFA5,Ig-like domain-containing protein,,19.3,18.9,18.7
A0A291NGS9,IgA constant region,,23.3,18.2,18.4
A0A2I2UJ66,Kazal-like domain-containing protein,,16.4,14.9,15.2
A0A337SA71,Selenoprotein P N-terminal domain-containing protein,,26.1,25.5,25.7
A0A2I2U8P7,Histone H2B,,22.3,18.5,18.8
A0A291NHD4,Ig lambda variable,,19.9,19.5,18.3
A0A5F5XIK4,Ig-like domain-containing protein,,18.3,20.5,20.9
A0A291NH79,Ig lambda variable,,22.4,20.7,21.1
A0A291NGT4,IgH variable region,,19.9,18.9,18.9
